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1. Abstract 
The nucleus in eukaryotic cells is enclosed by a nuclear envelope consisting of an inner and 
outer membrane, nuclear pore complexes, and in metazoans a filamentous lamina meshwork 
underlying the inner nuclear membrane. The lamina consists of intermediate filament-type 
proteins, the lamins, and numerous integral inner nuclear membrane proteins. Among these, a 
family of membrane proteins contain a conserved structural motif, called LEM domain (LAP2, 
Emerin, MAN1), which interacts with the DNA binding molecule BAF (barrier-to-
autointegration factor). LEM proteins have been implicated in chromatin organization and gene 
expression control and have been linked to a heterogeneous group of inherited human diseases, 
collectively termed “envelopathies”. This PhD thesis describes the identification and initial 
characterization of two novel LEM proteins, LEM2 and LEM3. 
LEM2 is ubiquitously expressed in many tissues and cell types and is closely related to MAN1 in 
primary sequence and domain topology. Complementation assays revealed that LEM2 is 
functionally conserved from yeast to man. In mammalian cells, it localizes at the inner nuclear 
membrane, interacts directly with A-type lamins and with BAF, and requires lamin A/C for 
nuclear envelope localization. The lamin A/C interaction domain was mapped to the N-terminus, 
while the C-terminus contains a conserved DNA binding motif. The latter was required for the 
ability of overexpressed LEM2 fragments to form patches at the nuclear envelope that recruit 
lamin A and lamin A-binding proteins, but exclude lamin B and associated proteins. Our data 
suggest a role of LEM2 in the spatial organization of protein complexes at the nuclear envelope 
and in chromatin organization at the nuclear periphery.  
LEM3 is primarily expressed in hematopoietic tissues such as bone marrow, thymus and spleen, 
and in lymphoma-derived cell lines, suggesting a B-cell related function. Analysis of LEM3 
domain topology revealed a cluster of Ankyrin repeats at the N-terminus and a conserved 
C-terminal GIY-YIG motif previously described in proteins with nuclease activity. I identified 
two LEM3 splice-isoforms lacking parts of the LEM domain. Unlike these isoforms full length 
LEM3 bound BAF. LEM3 misses a transmembrane domain and was found to shuttle between 
nucleoplasm and cytoplasm. In human cells ectopic LEM3 co-localizes with cytoplasmic actin 
filaments, while it is in nuclear splicing speckles upon pharmacological inhibition of nuclear 
export. Ectopic expression of LEM3 in the nucleus causes a mislocalization of BAF, cell cycle 
arrest, and activation of the ATM-dependent DNA damage pathway. We propose that LEM3 
may be involved in DNA recombination or repair pathways. 
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1. Kurzfassung 
Der Zellkern, das charakteristische Merkmal eukaryotischer Zellen, wird von einer Kernhülle 
eingeschlossen, die aus einer doppelten Lipidmembran mit eingefügten Kernporenkomplexen 
und einer filamentösen Kernlamina in mehrzelligen Arten, die der inneren Kernmembran anliegt, 
besteht. Mehrere integrierte innere Kernmembranenproteine enthalten ein spezifisches 
Strukturmotiv, die sogenannte LEM-Domäne (LAP2, Emerin, MAN1), die das DNA-bindende 
Molekül BAF (barrier-to-autointegration factor) bindet. Mutationen in LEM Proteinen wurden 
mit humanen Pathologien assoziiert, die in der heterogenen Gruppe der sogenannten 
"Envelopathien" zusammengefaßt werden. Zwei neue LEM Proteine, LEM2 und LEM3, wurden 
in der vorliegenden Dissertation identifiziert und analysiert.  
LEM2 ist ubiquitär in Geweben und Zelltypen exprimiert und ist sowohl bezüglich der 
Primärsequenz als auch der Domänen-Topologie eng mit MAN1 verwandt. Komplementations-
assays zeigten, daß Funktionen von LEM2 von der Hefe bis zum Menschen konserviert sind. In 
Säugetierzellen lokalisiert LEM2 an der inneren Kernhülle, interagiert direkt mit Lamin A/C und 
BAF und benötigt A-typ Lamine für die Lokalisation an der Kernmembran. Die Lamin A/C-
interagierende Region wurde auf einen Teil des N-Terminus eingegrenzt, wohingegen der 
C-Terminus ein DNA-Bindungsmotif enthält. Letzteres ist essentiell für überexprimierte LEM2-
Fragmente um Komplexe an der Kernhülle zu formen, die Lamin A und Lamin A-assoziierte 
Proteine rekrutieren können, jedoch Lamin B und Lamin B-assoziierte Protein exkludieren. 
Unsere bisherigen Daten weisen auf eine Rolle von LEM2 in der räumlichen Organisation von 
Komplexen an der Kernhülle und in der Chromatinorganisation an der Kernperipherie hin. 
LEM3 wurde vor allem in hämatopoietischen Geweben gefunden, so etwa im Knochenmark, 
Thymus und Milz, sowie in Lymphoma. Eine Analyse der LEM3 Domänenstruktur zeigte eine 
Gruppe von Ankyrin-Repeats am N-terminus des Proteins sowie ein evolutionär konserviertes 
GIY-YIG Motif innerhalb des C-Terminus welches zuvor in verschiedenen Proteinen mit 
Nukleasefunktion beschrieben wurde. Desweiteren habe ich zwei LEM3 Splice-Isoformen 
identifiziert bei welchen Teile der LEM Domäne fehlen, wobei diese im Gegensatz zum 
vollständigen LEM3 BAF nicht binden können. LEM3 enthält keine Transmembran-Regionen 
und wurde als Kern/Zytoplasma-„Shuttling“-Protein identifiziert. In menschlichen Zellen 
kolokalisiert LEM3 mit  cytoplasmatischen Aktin-Filamenten, während es nach 
pharmakologischer Inhibierung des Kernexports in nukleären “Splicing-Speckles“ zu finden ist. 
Ektopische Expression von LEM3 führte zu einer Mislokalisation von BAF, Zellzyklusarrest und 
Aktivierung des ATM-abhängigen DNA-Schädigungs-Signalweges. Wir postulieren eine 
Funktion von LEM3 in der DNA Rekombination oder im DNA Reparatur Signalweg. 
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2. Introduction 
2.1 The Nucleus – Evolutionary Aspects 
The nucleus, described first by the Scottish botanist Robert Brown in 1832, represents the largest 
subcellular compartment within eukaryotic cells and the presence of a nucleus is the major 
feature that distinguishes eukaryotes from the prokaryotic regna Eubacteria and Archae. Two 
hypotheses describe when and how the nucleus may have originated during evolution. According 
to the “endosymbiont hypothesis” (Fig. 1) the nucleus (as well as other cell organelles enclosed 
by a double membrane) originated by the incorporation of an early Archae bacterium into a 
eubacterium by an endocytosis process thereby forming a proto-eukaryotic cell (Lake and Rivera 
1994; Lopez-Garcia and Moreira 2006). Furthermore, it was proposed that the outer nuclear 
membrane (ONM) was established with the formation of the endoplasmic reticulum (ER) by 
fusion of internal cellular membranes of the host cell (Lopez-Garcia and Moreira 2006). 
 
Figure 1: The evolutionary origin of the nucleus according to the endosymbiont hypothesis. 
Adapted from (Lake and Rivera 1994). 
 
The endosymbiont model is also used to explain the origin of mitochondria and chloroplasts 
(Lang et al. 1999). Regarding the biochemical composition of the different organelle envelopes 
however, clear differences between the inner versus outer membrane sheets were noticed. 
Whereas the outer membranes of mitochondria and chloroplasts, like the endoplasmic reticulum, 
contain cholesterol, diphosphatidylglycerin (synonymous: cardiolipin) is the major phospholipid 
within their inner membranes is (Schlame et al. 2000), which is also a component of the today’s 
bacterial cell membrane. In contrast, such a biochemical difference was never reported between 
the inner and outer nuclear membrane of eukaryotic nuclei. According to lipid and protein 
composition, the nuclear envelope is more closely related to the ER membranes than to the inner 
membranes of mitochondria (Guidotti 1972). Therefore the endosymbiotic origin of 
mitochondria and chloroplast is mostly accepted today, but a similar scenario for the evolution of 
the nucleus is under heavy debate. It is also unclear how nuclear pore complexes, huge, essential 
protein assemblies present in all cell nuclei from yeast to man could have evolved. Nevertheless, 
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it may be possible that endosymbiotic bacteria may have existed over a long time as a rather 
independent symbiont, and nuclear pore precursors were established. Consequently, one would 
have to assume that during this time, the genetic information of the host cell was concentrated in 
this protonucleus and metabolic activities were transferred to the cytoplasm, which is hard to 
explain.  
The second hypothesis, which emerged some years ago, suggests a stepwise co-evolution of the 
nuclear envelope (NE) and the nuclear pore complex (NPC). 
 
Figure 2: The origin of the nucleus 
according to the hypothesis of a stepwise 
fusion of inner cell membranes. Adapted 
from “Basic Concepts in Biology”, Brooks-
Thomson, 2003 
From our current view of evolution, this 
scenario seems more conceivable than the 
endosymbiose model. The quintessence of 
this hypothesis is the gradual fusion of 
internal cellular membrane systems over a 
long time period, finally giving rise to the 
ER of eukaryotic cells, and additionally 
resulted in a completely enveloped genome 
(Fig. 2+3) (Martin and Koonin 2006). 
The fact that in eukaryotic cells the ER is 
continuous with the outer nuclear membrane 
fits to the view of a nuclear envelope that 
derived from the same membranes, which 
gave rise to the ER. Additionally it was 
suggested that planctomycetes, an 
exceptional class of bacteria that contains in 
contrast to all other known bacterial classes
internal membranes, partially enclosing the bacterial genome, may represent such early stages of 
nuclear evolution (Fuerst 2005; Martin and Koonin 2006; Pennisi 2004).  
A pathbreaking study by Devos and colleagues postulates that the key developmental step for the 
evolution of all internal membrane structures and subsequently for the formation of the nuclear 
envelope and nuclear pore complex in todays eukaryotic cells was the generation of protein 
modules, which allowed bending and stabilizing sharp membrane curvatures (Fig. 3). In support 
of this model, some of the coating proteins in the yNup84/vNup107–160 subcomplex of the NPC 
are also found in coated vesicles and in both cases they are needed to stabilize the membrane 
curvature (Devos et al. 2004). 
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Independent of the origin of the nucleus, its formation led to the spatial separation of 
transcription and translation. The strict separation of transcription and translation machinery had 
fundamental implications for the regulation of gene expression and DNA replication. 
 
Figure 3: A probable model for the evolution of the nuclear pore complex and the key role of 
coating modules. Adapted from (Devos et al. 2004). 
 
This compartmentalization of cellular functions was complemented by the formation of two 
major organelles, mitochondria and in plants additionally the chloroplasts through 
endosymbiosis (de Duve 2007). The uncoupling of transcription and translation and the location 
of distinct cellular functions to separate compartments is thought to be an essential prerequisite 
for the evolution of multicellular organisms. 
 
2.2 The Nuclear Structure Embedded In Cellular Networks 
The nucleus of all eukaryotic cells contains three major structural compartments. The nucleolus, 
mainly harboring ribosome biosynthesis (Hernandez-Verdun 2006; Raska et al. 2006), the 
nuclear envelope (NE), consisting of a lipid bilayer with inserted nuclear pore complexes (NPC), 
and the nucleoplasm (or nuclear interior) containing the chromatin and a multitude of subnuclear 
protein complexes with defined functions. Metazoan organisms contain additionally a 
filamentous structure at the NE, which underlies the inner nuclear membrane (INM), the 
so-called nuclear lamina. The nuclear lamina is thought to confer mechanical stability to the 
nucleus and provides an interaction platform for nuclear proteins and chromatin at the nuclear 
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periphery. Functional and structural data have been described in much detail for the nucleolus, 
the NE and the NPC, whereas the organization of the nuclear interior is still poorly understood. 
The NE is composed of inner and outer membrane sheets, which are separated by the perinuclear 
space and are linked at the NPCs (Fig. 4). Inner and outer nuclear membrane (INM, ONM) differ 
significantly in their composition of resident proteins and fulfill very different functions. The 
ONM belongs morphologically – and likely also evolutionary (see also chapter 2.1) – to the 
rough ER (rER) with which it is continuous. 
 
Figure 4: The nuclear envelope and its connection to the rough ER, the nuclear pore complex 
and the nuclear lamina. Adapted from (D'Angelo and Hetzer 2006). 
 
Consequently, not only the membranes, but also the perinuclear and the inner space of the ER 
are forming a continuous compartment. Recently it was reported that TorsinA and TorsinB, both 
resident proteins of the ER lumen, are also found in the perinuclear space and may interact with 
proteins of the INM and ONM (Hewett et al. 2004). Despite its continuity with the ER, the ONM 
also contains specific proteins, including the family of Nesprin proteins, which establish a link 
between proteins of the INM and the cytoplasmic actin cytoskeleton and microtubules (Crisp et 
al. 2006; D'Angelo and Hetzer 2006; Hetzer et al. 2005; Vlcek et al. 2001; Wilhelmsen et al. 
2006) (Fig. 5). This connection is established through specific interaction of two conserved 
protein domains in the perinuclear space: At the INM the C-terminal domain of SUN1 and SUN2 
(the eponymous SUN domain (Sad1-UNC84 homology)), interacts with the N-terminal KASH 
(Klarsicht, ANC1, SYNE1 Homology) domain of Nesprin proteins, which reside in the ONM 
(Tzur et al. 2006). As a completely closed NE would prevent any traffic of molecules between 
nucleus and cytoplasm, NPCs’, representing huge, symmetrically assembled protein complexes, 
form channels facilitating the molecular communication between these two cellular 
compartments. The NPC of higher eukaryotes consists of three super-imposed circular 
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structures: A cytoplasmic-, spoke- and nucleoplasmic ring, tightly fitting with the inner and outer 
nuclear membranes which are bent and fused at the spoke ring (Fig. 6).  
In contrast to the metazoan NPC, the yeast NPC consists only of a single ring structure, which is 
homologous to the spoke ring. At the nucleoplasmic side of all NPCs, eight nuclear filaments are 
 
Figure 5: Nuclear envelope and cytoskeleton form an integrated network. Adapted from (Tzur et 
al. 2006).  
 
protruding into the nuclear interior and are hold together by a distal protein ring, forming the so-
called “nuclear basket”. The cytoplasmic ring of the NPC is likewise decorated by eight 
filaments extending into the cytoplasm. Both, the nuclear basket as well as the cytoplasmic 
filaments have been reported to be involved in mRNA surveillance and export regulation (Forler 
et al. 2004; Lewis et al. 2007). Typically, a mammalian nucleus contains roughly 2000 NPCs, 
although the number may vary significantly depending on the physiological state of the cell 
(Adam 2001). NPCs permit passive diffusion of proteins smaller than 40kD but restrict passive 
movement of molecules with a higher molecular weight across the NE. The transport of these 
molecules depends on active transport mechanisms through the NPC. Both, the overall structure 
of the NPC and the molecules involved in active nuclear transport, are well conserved 
throughout the eukaryotic kingdoms and can be found already in unicellular organisms. Integral 
membrane proteins of the INM represent a special case in terms of nuclear import as these 
proteins are synthesized into the ER membrane and stay membrane-bound. 
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Figure 6: The NPC imaged by cryo-
electron microscopy. Adapted from (Beck 
et al. 2007). Cytoplasmic- (CR) Spoke- 
(SR) and Nucleoplasmic Ring (NR), 
Nuclear Filaments (NF), Distal Ring 
(DR). 
Several possibilities for the transport mechanism 
of integral membrane proteins to the INM have 
been suggested. A passive diffusion along the 
membrane continuities and subsequent retention 
by specific interactions was assumed previously. 
Recently, it was shown that integral proteins of 
the INM translocate along the membrane 
continuity at the NPC from the outer to the INM, 
but these proteins have to contain a nuclear 
localization signal (NLS) and use an active 
transport mechanism (King et al. 2006; Lusk et 
al. 2007). Integral INM proteins are retained at 
the nuclear periphery by specific interactions 
with chromatin, the nuclear lamina or other INM 
proteins. Whereas the main components of the 
NE and NPC as well as the nuclear lamina have 
been studied intensely, the structural and 
biochemical nature of the nuclear interior is still
poorly defined. Persistently the existence of a “nuclear matrix” was proposed (Pederson 2000; 
Verheijen et al. 1988) mainly by use of transmission electron microscopy (Fig. 7) or in living 
cells (Fig. 8). However, the actual nature of this postulated protein matrix, which is supposed to 
be intermingled with chromosomes, various RNA species, hRNPs (heterogeneous 
RiboNucleoProteins), snRNP (small nuclear RiboNucleoProteins) and subnuclear bodies could 
not be determined on a biochemical level so far. It is still an open question whether this matrix is 
determined by the chromatin, by unknown nuclear matrix proteins or a combination of both 
(Nalepa and Harper 2004; Nickerson 2001; Pederson 2000). Independent of the existence of a 
nuclear matrix the nuclear interior seems to be heavily structured. Several studies presented 
evidence that individual chromosomes are not distributed randomly within the nucleus, but are 
assigned to specific areas, dependent on the cell type and physiological state of the cell. These 
defined regions occupied by specific chromosomes are called “chromosome territories” (Foster 
and Bridger 2005; Lanctot et al. 2007) and are thought to have fundamental effects on gene 
expression patterns. Extrinsic signals are thought to induce the translocation of specific 
chromosome territories to other intranuclear sites, facilitating the transcriptional activation or 
silencing of specific chromosomal regions (Bartova et al. 2002; Kuroda et al. 2004). 
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Figure 7: Electron micrograph of 
cytoplasmic filaments and the nuclear 
matrix of a human cell. Adapted from 
(Verheijen et al. 1988). Intermediate 
filaments (IF), nuclear matrix (NM), 
nuclear pore (NP).  
Besides the chromosome-territories several 
types of “nuclear bodies” were identified over 
the past decades including Cajal bodies (Cioce 
and Lamond 2005), Nuclear Speckles 
(Lamond and Spector 2003) and PML bodies 
(Dellaire and Bazett-Jones 2004). Each of 
these discrete structures contain a specific set 
of proteins, chromatin and RNA molecules and 
fulfill particular functions in mRNA splicing 
and processing, DNA damage response and 
repair, micro-RNA processing and DNA 
replication (Lamond and Sleeman 2003; 
Lamond and Spector 2003; Matera 1999; 
Spector 2001). Most nuclear bodies are highly 
dynamic structures that are able to move 
within the nucleoplasm but assemble or 
disassemble according to the current
requirements of the cell (Lamond and Sleeman 2003). 
 
Figure 8: Evidence for a nuclear matrix in living cells, 
expressing GFP-tagged CDC14b (Nalepa and Harper 
2004). 
All together, the eukaryotic 
nucleus represents much more 
than a simple storage place for 
the genetic library of the cell. It is 
a highly organized and dynamic 
organelle with a plethora of 
subnuclear compartments 
regulating, organizing and 
integrating the different extrinsic 
and intrinsic signals in the 
“command centre” of the cell.  
The big challenge in the future will be to draw a holistic concept of how the nucleus with all its 
different functions is organized at the molecular level and how the individual structural 
components organize and regulate this highly complex interplay of specific functions. 
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2.3 The Nuclear Lamina 
The nuclear lamina, a filamentous protein network, was identified underneath the inner nuclear 
membrane of eukaryotic cells, with the exception of unicellular species (Aebi et al. 1986; 
Bridger et al. 2007; Foisner 2001; Gruenbaum et al. 2003) (Fig. 9). 
There is no direct proof yet of a functionally related structure present in unicellular eukaryota 
like yeast or dinoflagellates, although previous studies claimed the existence of a lamina-like 
structure, mainly based on antibody cross-reactivity (Enoch et al. 1991; Galcheva-Gargova and 
Stateva 1988; Georgatos et al. 1989; Minguez et al. 1994). The nuclear lamins, which build the 
nuclear lamina in higher eukaryotes, are classified as type V intermediate filaments (Table 1) and 
represent the only filamentous protein structures within the nucleus known so far. The 
evolutionarily “earliest” organism with a clear, defined nuclear lamina is the nematode 
Caenorhabditis elegans. The nuclear lamina of C.elegans is composed of a single type of lamin, 
considered an equivalent to higher eukaryotes’ B-type lamins, but more likely may be an 
ancestral lamin that split up in A-and B-type lamins later during evolution. 
 
Figure 9: The Nuclear Lamina of a Xenopus 
oocyte visualized by electron microscopy. 
Adapted from (Aebi et al. 1986). 
The “lowest” organism in evolution 
identified so far containing both, A-and 
B-type lamins, is D.melanogaster. In 
mammals, three independent genes encode 
all nuclear lamins. A-type lamins, 
Lamin A and C, are encoded by a single 
gene that is alternatively spliced, the 
B-type Lamins, Lamin B1 and B2, are 
encoded by two individual genes (Broers 
et al. 1997; Foisner 2001). In addition to 
the major lamin variants, two minor 
isoforms of Lamin A and C are known: 
Lamin AΔ10 (Machiels et al. 1996) and 
Lamin C2 (Furukawa et al. 1994),
as well as a minor splice isoform of Lamin B2, termed Lamin B3 (Furukawa and Hotta 1993). 
Lamin C2 and Lamin B3 were reported to be germ cell specific. The expression of at least one 
major B-type lamin is essential for cell survival (Vergnes et al. 2004), whereas A-type lamins 
seem to be dispensable for cell viability (Fong et al. 2006) and are expressed in differentiated 
cells only (Constantinescu et al. 2006; Rober et al. 1989). Despite the fact of the discovery of 
nuclear Actin and Actin-related proteins (ARPs) (Chen and Shen 2007; Goodson and Hawse 
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2002; McDonald et al. 2006; Pederson and Aebi 2005) and a nuclear form of Myosin I (Pestic-
Dragovich et al. 2000), the nuclear lamina represents the only proteinaceous filament network 
within the nucleus known so far. Actin and Myosin I, both well known constituents of the 
filamentous cytoskeleton, were reported to exist in the nucleus in a different conformation as 
compared to the cytoplasm (Jockusch et al. 2006). 
The proposed functions of the nuclear lamina can be grouped into two major activities. First, the 
supply of mechanical stability and structure to the nucleus preventing the physical collapse of the 
nuclear sphere, especially in tissues exposed to mechanical stress (for instance in skeletal muscle 
fibers) (Gotzmann and Foisner 2006; Houben et al. 2007; Lee et al. 2007) and second, a role in 
gene expression supported by the reported interaction of lamins with transcriptional regulators, 
such as pRB, chromatin and chromatin organizing components, such as Histones and BAF 
(Barrier-to-Autointegration Factor) (Bridger et al. 2007; Gotzmann and Foisner 2006; 
Gruenbaum et al. 2003). Both functions of the nuclear lamina can help to explain the diverse 
 
Table 1: Classification of intermediate 
filaments in vertebrates. Adapted from 
(Strelkov et al. 2003). 
phenotypes observed in a highly 
heterogeneous group of inherited human 
diseases caused by mutations in the 
Lamin A/C gene or in integral membrane 
proteins binding to Lamins A/C (Gotzmann 
and Foisner 2006). This group of late-onset 
diseases is collectively termed 
“laminopathies” and includes such different 
phenotypes as muscular dystrophy, dilated 
cardiomyopathy, lipodystrophy, bone 
structure- and skin defects and most severely, 
a premature aging pathology (see also chapter 2.4). Besides their well-characterized filamentous 
structure at the nuclear periphery, nuclear lamins were also found in the nuclear interior, mostly 
in intranuclear foci (Gotzmann and Foisner 1999; Muralikrishna et al. 2001). Nucleoplasmic 
Lamins A/C, together with the nuclear protein LAP2α (Lamina-associated Polypeptide 2), was 
also shown to stabilize and thereby regulate the crucial cell cycle regulator and differentiation 
factor Retinoblastoma Protein (pRB) (Johnson et al. 2004; Pekovic et al. 2007). Clearly these 
findings corroborate the current notion, that Lamins A/C are not only needed for the mechanical 
stability of the nucleus and the structure of the nuclear envelope, but are actively involved in the 
regulation of cell cycle progression (Dechat et al. 2007; Dyer et al. 1997) and differentiation 
(Boguslavsky et al. 2006; Constantinescu et al. 2006). 
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2.4 Human Diseases associated with the Nuclear Envelope 
During the last decades a multitude of severe, inherited human diseases were linked to mutations 
in several resident proteins of the nuclear envelope or lamina and collectively termed 
“Envelopathies” (Nagano and Arahata 2000; Somech et al. 2005a) or more specifically, 
“Laminopathies” (Worman and Bonne 2007). Envelopathies affect diverse somatic tissues, 
including skeletal and heart muscle, adipose tissue, the nervous system, skin, bone structure and 
blood cells, consequently causing a broad variety of cellular (Fig. 10) and clinical phenotypes 
(http://www.ncbi.nlm.nih.gov/OMIM) (Rankin and Ellard 2006). The most common feature of 
envelopathies is a late onset muscular dystrophy as observed in Emery-Dreifuss Muscular 
Dystrophy (EDMD) (Muchir and Worman 2007) and heart problems like dilated 
cardiomyopathy (DCM), but each patient shows an individual pattern of phenotypes, which vary 
significantly in severity.  
 
Figure 10: Summary of currently known gene defects linked to human diseases. Restrictive 
Dermopathy (RD), Mandibuloacral Dysplasia A/B (MADA/MADB), Pelger-Huet Anomaly 
(PHA), Adult-onset Autosomal dominant Leukodystrophy (ADLD), Limb-Girdle Muscular 
Dystrophy 1b (LGMD1b), Charcot-Marie-Tooth syndrome 2B1  (CMT2B1), Familial Partial 
Lipodystrophy (FPLD), Werner Syndrome (WNR). Adapted from (Worman and Bonne 2007). 
 
Confusingly, the position of the mutation does not predict the prevalent disease phenotype of the 
patient in most cases. Even within a single affected family different family members carrying the 
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identical mutation, may exert divergent pathological phenotypes. So far, there is no conclusive 
explanation for this phenotypical plasticity. At the cellular level, abnormal nuclear shapes and 
altered gene expression profiles were reported (Gotzmann and Foisner 2006; Maraldi et al. 2005; 
Maraldi et al. 2006; Mounkes et al. 2003; Worman and Bonne 2007). 
The most systemic pathology linked to Lamin A/C mutations known is the Hutchison-Gilford 
premature aging syndrome (HGPS), affecting essentially all tissues in the body of patients 
(Halaschek-Wiener and Brooks-Wilson 2007; Hennekam 2006; Kudlow et al. 2007).  
The triggers for this severe disease are mutations in the LMNA gene leading to aberrant splicing 
of the Lamin A/C mRNA. This results in the accumulation of an unprocessable, stably 
farnesylated pre-Lamin A/C in the nucleus, which is thought to be the cause for the molecular 
pathologies of the disease. The molecular details why the pre-Lamin A accumulation leads to 
accelerated aging is still unknown. One of the most pressing questions in the field today is how 
mutations in the Lamin A/C gene can give rise to such a variety of disease phenotypes. Currently 
more than two hundred disease-causing mutations have been mapped all along the Lamin A/C 
gene (Fig. 11). 
 
Figure 11: Identified mutations linked to inherited diseases in the Lamin A/C gene. Adapted from 
(Worman and Bonne 2007). 
 
As most envelopathies have a late onset during childhood, one hypothesis is that these mutations 
specifically affect the function of somatic stem cells thereby impairing tissue regeneration 
(Gotzmann and Foisner 2004; 2006). Therefore, patients may show no obvious phenotype at 
birth, but health problems appear as soon as tissue regeneration is required.  
Aside from mutations mapped within the Lamins A/C gene itself, also defects in genes encoding 
proteins involved in the posttranslational processing of Lamins A/C give rise to clinically similar 
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diseases. Both, Lamin A- and B-type lamins are C-terminally modified with a farnesyl group, but 
whereas B-type lamins are incorporated into the nuclear lamina as farnesylated proteins, A-type 
lamins undergo further processing. These maturation steps include two C-terminal cleavage steps 
by the enzyme Zmpste24. Deleterious mutations in the Zmpste24 gene cause an accumulation of 
premature Lamin A within the nucleus, which was also associated with HGPS. 
These findings suggest that a tightly controlled balance between pre-and mature Lamin A/C in 
the nucleus is essential for viability. Interestingly this balance may also be important in the 
regular human aging process (Vlcek and Foisner 2007).  
All together, the nuclear lamina and the proteins associated with the nuclear envelope exert 
pivotal regulatory functions in the nucleus – far beyond a simple structural role. With a very high 
probability, much more disease phenotypes will be linked to mutations in already known or in 
any of the 60 novel – so far not characterized – INM proteins in the future. One of the major 
aims in this field is the elucidation of the molecular pathways disturbed by disease-causing 
mutations, as this will enable clinical research to develop new strategies for therapies in the 
future. 
 
2.5 LEM-Domain Containing Proteins at the Nuclear Periphery 
The LEM protein family comprises several proteins that contain an about 40 aa long structural 
motif termed LEM (LAP2-Emerin-MAN1) (Cai et al. 2001; Laguri et al. 2001; Lin et al. 2000), 
which was found to interact with the DNA cross linking protein BAF ((Shumaker et al. 2001), 
see also chapter 2.6). The founding members of the family constitute several LAP2 isoforms, 
Emerin and MAN1 and database searches revealed the existence of other potential
LEM domain containing proteins in the mammalian genomes (provisionally termed LEM2, 3, 4 
and 5; (Lee and Wilson 2004)). While the LEM domain was initially described as a conserved 
stretch forming a helix-loop-helix motif (Cai et al. 2001; Laguri et al. 2001; Lin et al. 2000) 
(Fig. 12) in nuclear proteins, from an evolutionary point of view it may have evolved from an 
ancient helix-loop-helix motif functioning as a DNA binding domain. Later in evolution this 
domain developed into two separate motifs, namely the SAP domain (SAF A/B, Acinus, PIAS) 
(Fig. 13) and the actual LEM domain (Mans et al. 2004). Whereas the SAP domain still 
represents a motif which binds directly to DNA (Aravind and Koonin 2000), the LEM-domain 
establishes dynamic protein-chromatin complexes indirectly via interaction with a small, DNA-
crosslinking molecule termed BAF (Barrier-to-Autointegration-Factor) (see also chapter 2.6) 
(Shumaker et al. 2001). 
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Most of the so far analyzed LEM proteins contain at least one transmembrane domain, reside at 
the INM (Wagner and Krohne 2007) and interact with the nuclear lamina. The only clearly 
reported exception among the otherwise membrane anchored LEM proteins is LAP2α, a specific 
LAP2 isoform lacking a transmembrane domain and localizing in the nucleoplasm.  
A proposed major function of the nuclear lamina and its associated proteins is the maintenance 
of nuclear integrity and the organization of the peripheral chromatin (Fig. 14) (Sullivan et al. 
1999; Vergnes et al. 2004; Verstraeten et al. 2007; Wagner and Krohne 2007). The nuclear 
periphery has previously been characterized as a nuclear region with increased levels of dense 
heterochromatin (Figure 15) and was therefore proposed to constitute a transcriptional silent 
region within the nucleus. Dense patches of peripheral heterochromatin are only interrupted by 
euchromatic areas at the NPCs (Akhtar and Gasser 2007). 
 
Figure 12: Structure of the LEM-domain. 
Adapted from (Cai et al. 2001). 
 
Figure 13: Structure of the SAP-domain. 
Adapted from the “Pfam” database 
(www.pfam.sanger.ac.uk) 
 
There is increasing evidence that proteins at the INM and nuclear lamina (Figure 13) exert 
important regulatory functions also on the transcriptional activity of attached chromosomal 
regions (Bakay et al. 2006; Masny et al. 2004; Somech et al. 2005b; Verstraeten et al. 2007).  
 
Figure 14: Schematic drawing of known inner nuclear membrane and their interactions at the 
nuclear periphery. Adapted from (Wagner and Krohne 2007). 
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Surprisingly, MAN1, a well known INM LEM protein, was found to be directly involved in 
TGFβ and BMP signaling via specific tethering of Smad proteins at the NE (Bengtsson 2007) 
and Emerin, another long known LEM protein at the INM, was reported to regulate β-Catenin 
activity (Markiewicz et al. 2006). These findings drew a lot of attention to the molecular analysis 
of INM components and this broad interest was even further enhanced by the discovery that a 
heterogeneous disease group, termed “envelopathies”, is linked to mutations in some of these
 
Figure 15: Electron micrograph of a 
mammalian cell nucleus. Adapted from 
(Akhtar and Gasser 2007) 
proteins. Recently, a proteomic screen 
performed by Schirmer and colleagues 
identified about 60 novel integral INM 
proteins in rat liver cells, which were termed 
NETs 1-62 (Nuclear Envelope 
Transmembrane) (Schirmer et al. 2003; 
2005). About one third of the human NET-
encoding genes have been mapped to known 
dystrophy-linked chromosomal regions, 
suggesting important roles of nuclear 
envelope proteins in regulatory functions of 
skeletal muscle physiology. Aside from 
diseases affecting muscle tissue, a broad
diversity of disease phenotypes were linked to mutations in INM proteins or nuclear lamins (see 
also chapter 2.4) which suggests that these proteins may have particular tissue- or cell type 
specific functions.  
The functional characterization of one novel protein identified by Schirmer et al., NET25, which 
was then found to be a Lamin A-interacting LEM domain containing protein and thus was 
renamed LEM2, was a major topic of this thesis. 
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2.6 Barrier-to-Autointegration Factor – a BAFling Little Protein 
The following manuscript introduces the interaction partner of LEM domain containing proteins, 
BAF. This chapter gives a brief overview of the content of the review article and highlights 
additional important findings, which were not included in the review.  
BAF (Barrier-to-Autointegration Factor) is a small, abundantly expressed, highly conserved 
protein, which was initially identified as a cellular component preventing the autointegration of 
retroviral DNA, and favors its integration into the host genome. It was then discovered, that BAF 
mediates the interaction of LEM proteins with chromatin. BAF itself binds to double-stranded 
DNA in a non-sequence specific way (Cai et al. 1998). A comprehensive structural study of the 
LEM-BAF complex revealed that a LEM domain/BAF/DNA complex could only be formed by a 
BAF dimer that binds two DNA strands and a single LEM domain. According to the authors, this 
configuration prevents the formation of mixed complexes with more than one LEM-protein (Cai 
et al. 2007). Besides the LEM domain, BAF interacts with multiple other nuclear components 
including histones H1.1 and H3 (Montes de Oca et al. 2005), lamins and various homeodomain 
transcription factors (Wang et al. 2002). BAF exerts functions in several cellular processes, such 
as chromatin organization and compaction, regulation of transcription, developmental functions 
and nuclear envelope assembly (Margalit et al. 2007a). Recently, BAF was identified as a 
regulator of cell fusion in C. elegans by inhibiting the expression of the fusogen protein eff-1 
through specific binding to the eff-1 promoter (Margalit et al. 2007b).  
So far, the intracellular localization of BAF was supposed to be primarily nuclear as all 
described BAF interaction partners are found there. Recently, Haraguchi and colleagues reported 
that BAF localization is dependent on the physiological state of cells and they claim that BAF is 
translocated from the nucleus to the cytoplasm upon transition to senescence. In contrast, 
immortal cell lines also exhibited high levels of cytoplasmic BAF, leading to the speculation that 
the nuclear fraction of BAF suppresses cellular senescence as well as cancer progression in 
non-transformed cells. Furthermore, nuclear BAF was found to be associated with S-phase 
progression in both mortal and immortal cells (Haraguchi et al. 2007). In addition, a highly 
related protein termed BAF-like has recently been reported, which forms homo- and 
heterodimers with BAF in vitro. Interestingly, the BAF-like homodimer showed no significant 
binding affinity to DNA and both the homo- and heterodimer did not bind to the LEM domain in 
vitro, corroborating the finding of Cai and colleagues (Cai et al. 2007) that only a BAF 
homodimer is able to form a complex with DNA and the LEM domain. Consequently, it was 
proposed that the BAF-like protein might function as a modulator of BAF interactions (Tifft et 
al. 2006). 
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2.7 Aims of the Thesis 
Since the discovery that a heterogeneous group of human diseases termed “envelopathies” is 
genetically linked to the nuclear lamina and INM proteins, these proteins became a major focus 
in the field of nuclear research. Among about 60 different INM proteins, a subset of proteins 
contains a specific structural motif called LEM domain. Defects in three known LEM proteins, 
LAP2, Emerin and MAN1, were linked to human pathologies included in the group of 
envelopathies. Novel members of the LEM domain containing protein family are therefore 
considered to be potential candidates for disease causing genes involved in human pathologies. 
This notion is further supported by the fact that only a limited percentage of investigated cases of 
clinically diagnosed envelopathies revealed mutations in known proteins of the nuclear lamina or 
INM. 
As a detailed knowledge on the expression, interactions and properties of these proteins is a 
prerequisite for understanding the molecular basis of these diseases, the aim of this thesis was 
the identification and functional characterization of novel mammalian LEM proteins. 
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3. Results 
3.1. Evolution of the LEM Domain Containing Protein Family 
The increasing availability of databases providing complete sequence data of many organisms 
allowed us to perform a screen for evolutionary conserved LEM domain proteins and to identify 
potentially important regions within these proteins by sequence alignments. 
In general the number of different LEM domain proteins increased during evolution, reaching a 
predicted number of seven individual genes within the genome of mammalian species. These 
include Emerin, LAP2, MAN1, LEM2, LEM3, LEM4, and LEM5 (Table 2). LEM2 was the only 
gene identified to have an ortholog in yeast, whereas four genes (Emerin, LEM2, LEM3 and 
LEM4) are present in C.elegans. Although genomic databases still contain some sequencing 
gaps, evolutionary models about the origin and growth of the LEM-domain containing protein 
family can be deduced. 
The first LEM domain containing protein that appeared in evolution might have been a LEM2 
precursor, which probably originated in an ancestral unicellular organism. Recently two putative 
LEM2 orthologous proteins have been identified in S.cerevisiae, SRC1 (Brachner et al. 2005; 
Rodriguez-Navarro et al. 2002) (also termed HeH1) and HeH2 (King et al. 2006). HeH1 was 
consequently found also in several other unicellular organisms (see also chapter 3.2.3 and 
Fig. 17). LEM2 and SRC1 share a common domain topology with one major difference: The 
N-terminal LEM motif of LEM2 is substituted by a SAP-like motif in SRC1 and HeH2 at the 
corresponding position. Since there exists no orthologous BAF protein in unicellular organisms 
(which binds to the LEM motif), a co-evolution of the LEM domain and BAF in early metazoan 
species seems a conceivable model (Margalit et al. 2007a). The switch from a direct binding to 
DNA of the SAP motif to an indirect binding of the LEM motif to DNA via BAF during 
evolution implies the generation of additional levels of regulation in protein-chromatin 
interactions during evolution. So far proteins containing a canonical LEM domain were found in 
C.elegans as the “earliest” organism, including three different proteins: ce-Emerin, ce-LEM-2 
(previously termed: ce-MAN1) and ce-LEM-3 (Lee et al. 2000). Interestingly, in LAP2 proteins 
a LEM-like domain was identified which has the capability to bind directly to DNA (Cai et al. 
2001) and which is more closely related to the SAP motif than to the LEM domain according to 
their calculated phylogenetic distance (Fig. 16). Although the LAP2 gene is only present in 
higher eukaryotes today (Table 2), the LEM-like motif might represent an intermediate structure 
which evolved at the transition from a SAP-like motif to the BAF-binding LEM motif and was 
preserved for unknown reasons in LAP2 proteins (no other proteins harboring a LEM-like motif 
have been found so far).  
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S.cerevisiae - SRC1 
HeH2 
- - - - - - - - 
C.elegans emerin lem-2 lem-3 - Y55F3BR 
** 
- - baf - lamin 
D.melanogaster - 
*** 
- LEM3* MAN1 SD02148p
** 
- - BAF LamC LamDm0 
C.intestinalis nd nd LEM3* MAN1* LEM4* nd nd BAF nd Lamin 1 
Lamin 2 
D.rerio nd nd LEM3* MAN1 LEM4* LAP2 nd BAF nd Lamin B1 
Lamin B2 
X.tropicalis nd nd LEM3* XMAN1
SANE 
LEM4* LAP2 nd BAF 
Lamin A 
Lamin III 
Lamin B1 
Lamin B2 
O. anatinus Emerin nd LEM3* nd LEM4* LAP2 nd BAF nd nd 
M.domestica nd LEM2* LEM3* nd LEM4* LAP2 nd BAF nd nd 
D. novemcinctus nd nd LEM3* MAN1* LEM4* LAP2 LEMD1 BAF nd nd 
E.telfairi nd nd LEM3* MAN1* LEM4* LAP2 nd BAF nd nd 
R.norvegicus Emerin LEM2 LEM3 MAN1 LEM4 LAP2 LEMD1 BAF 
BAF-L 
Lamin A/C
Lamin B1 
Lamin B2 
M.musculus Emerin LEM2 LEM3 MAN1 LEM4 LAP2 LEMD1 BAF 
BAF-L 
Lamin A/C
Lamin B1 
Lamin B2 
H.sapiens Emerin LEM2 LEM3 MAN1 LEM4 LAP2 
α,β,γ,δ,ε,ζ 
LEMD1 
a,b,c,d,e 
BAF 
BAF-L 
Lamin A/C
Lamin B1 
Lamin B2 
Table 2: LEM proteins present in selected organisms according to genomic database analyses.  
(*) Sequence present, but not annotated, (**) Sequence identified to be related to mammalian 
LEM4, but lacks predicted LEM-domain, (***) Two Arthropoda-specific proteins, Otefin and 
Bocksbeutel, are similar to the Emerin proteins. (nd) not determined due to sequencing gaps in 
genomic databases. 
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The alignment and calculation of the evolutionary relationship of all available sequences 
containing a LEM domain, revealed two related subgroups (Fig. 17) and three rather unrelated 
genes. 
 
Figure 16: Phylogenetic relation of human LEM, LEM-like and SAP motifs. Unrooted tree 
diagram calculated from sequence homologies between the LEM, LEM-like and SAP motifs of 
the indicated proteins. 
 
(1) LEM2 and MAN1 are highly related proteins and comprise a subgroup within the 
LEM protein family, which may have evolved from an early INM protein, which is still present 
in current unicellular eukaryotes. During evolution of metazoan organisms the MAN1 sequence 
emerged probably by a gene duplication of LEM2 and subsequently gained the MAN1-specific 
RRM motif, thereby adding a non-redundant unique function to MAN1. Interestingly the LEM2 
sequence could not be found in the genomic datasets of Arthropoda (including insects), 
Amphibia (including frogs) and Pisces (including fishes), which could be explained by a loss of 
LEM2 during the evolution of these phyla or the LEM2 encoding genomic regions are not 
completely covered and sequenced yet. So far, Gallus gallus (chicken) was the “earliest” species 
identified containing both, LEM2 and MAN1 (Table 2 and Figure 15). 
(2) Emerin and LAP2 seem to have a common origin as well, of which Emerin was 
emerging earlier in evolution. Analogous to LEM2 and MAN1, LAP2 may have emerged by a 
gene duplication of Emerin. 
LEM3, LEM4 and LEM5 (Lee and Wilson 2004) evolved more independently. In the case of 
LEM4, the LEM domain evolved later in evolution, giving rise to two types of LEM4-related 
proteins, one with and one without a LEM motif. Based on primary sequence conservation, there 
are homologous genes to human LEM4 in C.elegans and D.melanogaster, which lack the 
characteristic LEM domain and thus are not considered members of the family of LEM domain 
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proteins (Table 2 and Fig. 17). Nevertheless, particular functions independent of the presence of 
a LEM motif might be conserved among all LEM4 related proteins. Therefore, data about these 
LEM4-related proteins might help elucidating the functions of LEM4 in higher eukaryotes.  
 
Figure 17: Evolution of the LEM-domain containing protein family. Unrooted tree diagram 
calculated from protein sequence alignments. 
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Except for LAP2, MAN1 and LEM5 all LEM proteins are present in C.elegans, indicating that 
this conserved family of proteins fulfils basic functions in multicellular organisms and may 
additionally confer functional redundancy to protect against genetic alteration induced loss-of-
function. A comparison of the predicted domain topology of all members of the LEM protein 
family reveals that, with only one exception, the predicted LEM domain is located either at the 
very N-terminus (Emerin, MAN1, LEM2 and LEM5) or within the N-terminal part (LAP2, 
LEM4) of the proteins. The same holds true for the LEM-like motif in LAP2 proteins. LEM3 
represents the only family member with a LEM domain located close to the middle of the protein 
sequence (Fig. 18). 
 
Figure 18: Predicted domain topology of the human LEM-domain containing protein family. 
Schematic protein topology (to scale) according to computational predictions, numbers indicate 
positions within the protein sequence. Chromosomal loci are indicated according to the 
ENSEMBL human genome database (http://www.ensembl.org). 
 
Whether the preferential localization of the LEM domain at the N-terminus of proteins is due to 
structural or functional reasons or both is unknown but it might be due to the fact that most of 
these proteins are anchored within the INM via one or two transmembrane domains located 
within the middle or C-terminal part (Fig. 18 and Table 3).  
For proteins with a single transmembrane domain, the N-terminal tail resides in the nucleoplasm 
thus all interactions with nuclear lamins, BAF or other nuclear proteins are restricted to the 
nucleoplasmic N-terminal part. In case of LEM2 and MAN1, which contain two transmembrane 
regions, both N-and C-terminus reside in the nucleoplasm and have the possibility to interact 
with nuclear components. The LEM motif is located at the N-terminus in both proteins and 
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additional functional motifs were predicted within the C-terminal part of the proteins (Fig. 18, 
and chapters 3.2.1 and 3.2.2). 
 Subcellular Localization Reference 
LAP2 INM, except LAP2α which localizes in the nucleoplasm (Dechat et al. 1998; Furukawa et al. 1995) 
Emerin INM (Manilal et al. 1996) 
MAN1 INM (Lin et al. 2000) 
LEM2 INM (Brachner et al. 2005) 
LEM3 nucleo-cytoplasmic shuttling protein unpublished, see chapter 3.3.1 
LEM4 unknown; in silico prediction: nuclear unpublished 
LEM5 INM (Yuki et al. 2004) 
Table 3: Subcellular localization of human LEM proteins as far as known from literature or in 
silico prediction. 
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3.2 LEM2 
LEM2 was identified in database screens as a putative novel LEM domain containing protein in 
mammalian organisms and was retrieved independently in a proteomic screen for novel, INM 
proteins (Schirmer et al. 2003). We cloned and analyzed human and murine LEM2 in order to 
verify its predicted characteristics and to detect potential laminopathy-related features. Initial 
localization studies using immunofluorescence and protein extraction experiments approved that 
this novel LEM protein is indeed a resident protein of the INM. All LEM domain containing 
proteins locating at the INM or in the nucleoplasm have been shown to interact with the nuclear 
lamins. Therefore, it was probable that also LEM2 interacts with lamins. We determined the 
lamin binding properties of LEM2 via in vivo and in vitro approaches and could show that LEM2 
N-terminus is interacting with the Lamin A/C tail region in a direct manner. 
Further on we observed two phenomena in cells overexpressing human LEM2. First, LEM2 
accumulates in patch-like structures at the NE and recruits Lamin A/C, BAF, Emerin as well as 
MAN1 to these patches, which likely represent large invaginations of the NE, as determined by 
transmission electron microscopy. Secondly, LEM2 affects nuclear envelope reassembly after 
mitosis as we frequently observed daughter nuclei still connected by a membranous bridge, 
although cells have completed cytokinesis (see chapter 3.2.1). 
Analysis of LEM2 fragments revealed a dominant inhibitory effect on cell cycle of LEM2 
N-terminus, which could be provoked by its interaction with nucleoplasmic Lamin A/C thereby 
perturbing the complex of Lamin A, LAP2α and the tumor suppressor pRB, which results in a 
cell cycle arrest. In contrast, overexpression of full length LEM2 was even accelerating cell 
proliferation indicating that localization and interactions with Lamin A/C and BAF in the nuclear 
interior or at the periphery causes entirely different effects (see chapter 3.2.2). 
Additionally we investigated the phylogenetic relationship of LEM2 and its proposed 
orthologous protein in yeast, SRC1, on a functional level. Therefore, we collaborated with the lab 
of Susana Rodriguez-Navarro, who performed complementation assays with human LEM2 in 
SRC1-/- yeast strains and could show that hLEM2 indeed is able to partially rescue the phenotype 
of the knockout strain. Additionally we performed localization studies of fluorescently tagged 
human LEM2 in yeast and found LEM2 to be targeted to the yeast NE. Taken together these 
results provide strong evidence for evolutionary conserved functions within the LEM2/SRC1 
superfamily (see chapter 3.2.3). 
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3.2.1 LEM2 is a Novel MAN1-related Inner Nuclear Membrane Protein 
         Associated with A-type Lamins 
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3.2.2 Localization and Phenotypic Consequences of Expressed LEM2 
         Protein Domains 
The N-terminal portion of human LEM2 has previously been identified to interact directly with 
Lamin A/C thereby anchoring the protein at the INM (Brachner et al. 2005). During the past 
years increasing evidence has linked Lamin A/C to cell cycle control, such as the discovery of a 
nucleoplasmic complex of Lamin A/C and Retinoblastoma protein (pRB) (Markiewicz et al. 
2002; Ozaki et al. 1994) a tumor suppressor and major cell cycle and differentiation regulator 
protein (Genovese et al. 2006). Furthermore, cells derived from lmna-/- mice were found to 
proliferate significantly faster than wild type control cells, an effect which was linked to 
decreased pRB stability (Johnson et al. 2004) and to the lack of the suppressive function of 
Lamin A on the transcription factor AP-1 (Activator Protein 1). Ivorra and colleagues reported 
that c-fos, together with c-jun, which form the functional AP-1 complex, is sequestered to the 
NE and thereby inactivated by interaction with Lamin A (Ivorra et al. 2006). Additionally, 
LAP2α as the only so far described nucleoplasmic LEM protein, was shown to reside in the 
complex with intranuclear Lamin A/C and pRB and was therefore suggested to function in the 
regulation of cell cycle progression and differentiation (Dorner et al. 2006; Dorner et al. 2007). 
Although controversial results regarding the proliferation phenotype of human and murine cells 
deficient for either Lamin A/C or LAP2α have been published, these data point towards a 
function of both nuclear proteins in controlling cell cycle progression (Pekovic et al. 2007). The 
structural conformation and function of intranuclear versus peripheral Lamin A/C is still unclear 
(Moir et al. 2000), but it was suggested that the distribution of Lamin A/C could influence cell 
cycle as well as differentiation (Markiewicz et al. 2005; Muralikrishna et al. 2001). Further on, 
an increased level of peripheral Lamin A/C was observed to be correlated with entry into 
senescence whereas the localization of a Lamin A/C subset to the nucleoplasm was intimately 
associated with a proliferative state (Dorner and Naetar, unpublished data). Following our 
previous finding that ectopically expressed LEM2 N-terminus is homogenously distributed 
within the nucleoplasm, likely through interaction with intranuclear Lamin A/C, we aimed at 
investigating the influence of LEM2 on Lamin A/C function regarding cell cycle regulation in 
more detail. 
A second structural motif, proposed to form a winged-helix like DNA binding structure (Caputo 
et al. 2006), which has previously been identified within MAN1 C-terminus may also exist in 
LEM2. This domain, termed MSC motif, is highly conserved in primary sequence between 
LEM2 and MAN1 and was described as an evolutionary conserved motif by computational 
analyses (Brachner et al. 2005; Mans et al. 2004) (the MSC motif was recently included in the 
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“PFAM”-database: PF09402). Hence, we aimed at elucidating the putative role of this motif 
within the LEM2 protein. One prominent feature of LEM2 upon ectopic expression in cells was 
the formation of protein patches at the nuclear envelope, which were resolved as large membrane 
invaginations at the ultrastructural level. Analyzing various LEM2 deletion constructs revealed 
that this putative DNA-interacting domain was required for the formation of patches, pointing to 
a role of LEM2 in organizing the chromatin structure at the nuclear periphery. 
 
Results 
Distinct domains contribute to LEM2 localization at the nuclear envelope 
In order to characterize LEM2’s individual domains in more detail, we tested the localization 
pattern and the influence of stably expressed full-length LEM2 or various LEM2 fragments 
missing the LEM, MSC or both domains, on cell cycle control. Whereas HeLa cells 
overexpressing ectopic full-length LEM2 were readily generated, only few clones with low 
expression levels could be obtained for expressing LEM2 lacking the LEM domain or both LEM 
and MSC domain (LEM2ΔL and LEM2ΔLM respectively). Repeatedly, no clones with stable 
expression of LEM2ΔMSC (LEM2ΔM) were viable. This indicated that, unlike full-length 
LEM2, LEM2-fragments are toxic to cells. Expectedly, all transiently expressed fragments were 
targeted to the NE, though with different efficiencies and showed a prominent nuclear rim 
staining or peripheral patches in immunofluorescence microscopy (Fig. 19). Whereas LEM2ΔL 
showed the LEM2-typical patch formation at the NE (Brachner et al. 2005), LEM2ΔM and 
LEM2ΔLM were distributed homogenously along the nuclear rim barely exhibiting 
accumulation in patches at the NE. Interestingly, formation of patches is a specific feature of the 
LEM2 protein as overexpressed human MAN1 exhibited homogenous distribution along the NE, 
despite the fact that the MSC motif is highly conserved between both proteins (Fig. 19, lower 
panel).  
Retention of LEM2ΔL at the NE was slightly and that of LEM2ΔLM significantly reduced as 
indicated by an increase of fluorescent signal in the ER and cytoplasm (Fig. 19). The formation 
of NE patches as well as the connecting tubes between nuclei of adjacent cells as observed 
previously upon overexpression of LEM2 (Brachner et al. 2005) was found to be strictly 
dependent on the MSC motif, while the LEM domain seemed to contribute only slightly to this 
property (Table 4). Constructs lacking the C-terminus neither formed patches nor links, and 
LEM2ΔLEM showed patch formation with reduced frequency. Furthermore, the insertion of the 
fragments into the membrane was essential for patch formation, as expression of a C-terminal 
fragment without the transmembrane domains did not form patches or links (data not shown). 
Further on we tested the recruitment of BAF to NE patches, which is a supposed binding partner 
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of LEM2, previously shown to co-localize with LEM2 patches (Brachner et al. 2005). As 
expected, constructs lacking the LEM domain, i.e. LEM2ΔL and LEM2ΔLM, did not recruit 
BAF (Fig. 20A). 
 
Figure 19: Immunofluorescence images of HeLa cells expressing LEM2-V5, MAN1-V5 or 
various human LEM2 deletion fragments. Schematic drawing of constructs: Orange box (LEM 
domain), red (transmembrane domain), violet (MSC motif), turquoise (RRM motif). 
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 NE patches NE links 
LEM2 + + 
LEM2ΔLEM +, reduced frequency +, reduced frequency 
LEM2ΔMSC – – 
LEM2ΔLEMΔMSC – – 
Table 4: Occurrence of NE patches and links upon ectopic expression of LEM2 constructs. 
 
 
Figure 20: Immunofluorescence images of HeLa cells expressing LEM2-V5 or V5-tagged LEM2 
deletion constructs. (A) HeLa cells expressing LEM2 constructs were co-stained for V5 (green), 
DNA (blue) and BAF (red). Arrows: Patches of LEM2 at the NE. (B) HeLa cells expressing full-
length LEM2-V5 were stained for V5 (green), DNA (blue) and nucleoplasmic Lamin A/C (red). 
Arrow: Increased signal of Lamin A/C at the nuclear periphery. 
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These findings were further corroborated by in vitro binding assays performed in collaboration 
with Malini Mansharamani and Katherine Wilson (John Hopkins University School of Medicine, 
Baltimore, USA) (Fig. 21). Applying co-immunoprecipitation (Fig. 21A) and microtiter assays 
(Fig. 21B) it was shown that BAF bound directly to LEM2 containing the LEM-domain but not 
to LEM2ΔLEM or LEM2 C-terminus as it has been shown for MAN1 C-terminus 
(Mansharamani and Wilson 2005). 
 
 
 
Figure 21: (A) Direct binding of BAF to LEM2 fragments tested by co-immunoprecipitation and 
microtiter assays. Western blot (upper panel) showing immunoprecipitation results. 
Recombinant LEM2 (FL), LEM2-N-terminus (N), LEM2-NT ΔLEM (NΔLEM) or LEM2-C-
terminal (C) proteins were incubated with recombinant BAF in the presence (+) or absence (—) 
of antibodies against BAF. Immunoprecipitates were resolved by SDS-PAGE and western 
blotted with antibodies to V5 to detect LEM2 polypeptides. Asterisks (*) indicate nonspecific 
bands. (B) Microtiter assays. Recombinant purified BAF or BSA were immobilized in microtiter 
wells, incubated with 35S-labeled probe protein LEM2-full length (FL), LEM2-NTΔLEM 
(NΔLEM) or LEM2-C fragment (C), then washed and quantified (n=3 triplicate sets). Bars 
indicate standard deviations. Experiment was carried out by M. Mansharamani & K. Wilson 
(Baltimore, USA). 
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In accordance with Ulbert and colleagues who reported that hLEM2 downregulation impairs cell 
cycle progression in HeLa and U2OS cells (Ulbert et al. 2006), we recognized different 
proliferation rates of HeLa cells stably expressing LEM2 fragments under standard cultivation 
conditions. Expression levels of ectopic proteins were determined by Western blot analysis 
(Fig. 22). Highest expression levels were observed for full-length LEM2. Interestingly, these 
 
 
 
 
Figure 22: Western blot analysis of lysates 
prepared from HeLa single cell clones 
stably expressing V5-tagged full-length 
LEM2 or LEM2 deletion constructs. 
cells also grew faster than untransfected 
HeLa. In contrast, LEM2ΔL and 
LEM2ΔLM were expressed at significantly 
lower levels and stable cells expressing 
these fragments reduced proliferation 
compared to control cells. Growth curve 
analyses with different clones were done to 
confirm these data. Three different single 
cell clones expressing full-length LEM2 
proliferated significantly faster than 
untransfected HeLa cells, whereas one clone 
expressing LEM2ΔL and two out of three 
clones expressing LEM2ΔLM showed 
reduced proliferation (Fig. 23).  
 
 
Figure 23: Growth curve of HeLa cells as well as different single cell clones stably 
overexpressing full-length LEM2, LEM2ΔL or LEM2ΔLM constructs. 
 
Interestingly, overexpression of full-length LEM2 in cells caused a partial relocalization of 
nucleoplasmic Lamin A/C to the periphery (Fig. 20B), which may contribute to the observed 
influence on proliferation. 
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Expression of LEM2 N-terminal fragments recruits peripheral Lamin A/C to the nuclear 
interior and causes cell death 
In our previous studies we defined a stretch of about 60 aa length within the LEM2 N-terminus 
to interact directly with A-type Lamins (Brachner et al. 2005). Ectopically expressed LEM2 
N-terminal fragment lacking the transmembrane domain was localized primarily within the 
nucleoplasm in HeLa cells, while it localized to the nucleoplasm and cytoplasm in lmna-/- 
fibroblasts. Intriguingly, the amount of intranuclear Lamin A/C in cells expressing LEM2 N-
terminal fragments (LEM2-NT) was slightly increased as compared to untransfected cells 
(Fig. 24, “Lamin A/C N18” and “Lamin A 133A2”). The increase in nucleoplasmic Lamin A/C 
was though quite subtle because specific staining for intranuclear lamins (Fig. 24, “McKeon”) 
did not show a clear difference between transfected and control cells. The localization and 
protein levels of Lamin B1, LAP2β, and LAP2α were not affected by LEM2-NT (Fig. 24). 
Generally, the distribution of LEM2-NT within the nucleus was uniform in the majority of cells. 
Intriguingly, BAF staining intensity was reduced in cells expressing LEM2-NT. This may be the 
result of epitope masking of nucleoplasmic BAF through interaction with nucleoplasmic LEM2-
NT. Occasionally (in ~1% of transfected cells), however, we observed formation of patches of 
BAF at the NE in addition to reduced BAF staining in the nuclear interior, indicating that 
overexpression of LEM2-NT may also affect BAF localization (Fig. 25). 
As our attempts to generate stable cell lines expressing LEM2-NT repeatedly failed and no 
mitotic figures could be found in cells expressing LEM2-NT transiently, we speculated that the 
recruitment of Lamin A/C to the nuclear interior by LEM2-NT might disturb pRB functions and 
cause an inhibitory effect on cell cycle progression. In order to determine the capability of 
LEM2-NT expressing cells to cycle we co-stained for the proliferation marker Ki-67. As cells 
expressing L2-NT were positive for Ki-67, we assumed that LEM2-NT expression did not cause 
quiescence or senescence (Fig. 26).  
BrdU-labelling of cells revealed an increase in the relative number of S-phase cells in cultures 
expressing LEM2-NT compared to GFP and full-length LEM2 expressing controls (Fig. 27, 
“LEM2-NT”) (~45 versus 53% positive cells). It is unclear, however, whether this increase in 
S-phase cells is linked to the toxic effect of the LEM2-NT fragment. We speculate that the 
detrimental effect of LEM2 N-terminus on cell viability might be explained by induction of 
apoptosis or necrosis following activation of cell cycle checkpoints on impaired cell cycle 
regulation.  
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Figure 24: Immunofluorescence co-stainings of MEFs derived from Lamin A/C deficient mice 
and HeLa cells expressing myc- or V5 tagged LEM2 N-terminal fragments. Arrows: Lamin A 
recruited to the nuclear interior in transfected cells. 
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Figure 25: HeLa cells transiently expressing L2-NT were co-stained for BAF. In ~ 1% of 
transfected cells NE, patches of LEM2-NT and BAF were observed. 
 
 
Figure 26: HeLa cells transiently expressing L2-NT were co-stained for Ki-67. 
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Figure 27: Quantification of BrdU-positive cells 24h after upon transfection with plasmids 
encoding GFP, LEM2 or LEM2-N-terminus (LEM2-NT) and a pulse-label of 30 minutes. 
Approximately 200 cells were evaluated for BrdU-label, untransfected cells of the same sample 
were counted as control for transfection and labeling procedure. 
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LEM2 N-terminal fragments affect localization of ectopic full-length LEM2 at the nuclear 
envelope 
As Lamin A/C is required for localization of LEM2 at the NE (Brachner et al. 2005) we 
investigated the effects of LEM2-NT mediated Lamin A/C relocalization on the localization of 
full-length LEM2. Therefore, a myc-tagged LEM2-NT fragment was expressed in HeLa cells 
stably overexpressing full-length LEM2-V5. Interestingly, LEM2-V5 retention at the NE was 
significantly reduced in cells transfected with the LEM2-NT-myc construct (Fig. 28) indicating a 
competition of full-length LEM2 and LEM2-NT for binding sites at the nuclear periphery. This 
effect resembled the effect of a dominant Lamin B construct which aggregated peripheral 
Lamin A/C and caused displacement of LEM2-V5 from the NE (Brachner et al. 2005).  
 
Figure 28: Immunofluorescence images of a stable HeLa cell line expressing full-length LEM2-
V5 (green) and transiently expressing LEM2-NT-myc (red). 
 
Furthermore, we were interested in the localization and phenotypical consequences of the LEM2 
MSC domain. V5-, myc- and GFP-tagged C-terminal fragments of LEM2 (LEM2-CT) were 
expressed in HeLa cells, but neither V5- nor myc-tagged proteins were clearly detectable in the 
cells most likely due to toxic effects (data not shown).  
 
Figure 29: Immunofluorescence images of a stable HeLa cell line expressing full-length LEM2-
V5 (red) and transiently expressing GFP-LEM2-CT (green). 
 
GFP-LEM2-CT was found predominantly within the nucleus (Fig. 29), consistent with the 
proposed DNA-binding function of the MSC domain (Caputo et al. 2006). Localization of 
ectopic full-length LEM2 seemed unaffected by the co-expression of LEM2-CT (Fig. 29). 
However also GFP-LEM2-CT could not be stably expressed in cells, indicating a detrimental 
effect on viability probably by affecting chromatin functions. 
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LEM2 directly interacts with proteins of the nuclear periphery including A-and B-type 
Lamins, Emerin and MAN1 
In collaboration with Malini Mansharamani and Kathy Wilson (JHU School of Medicine, 
Baltimore, USA) we investigated the binding properties of human LEM2 to the previously 
proposed binding partners, i.e. Lamins, Emerin and MAN1, in more detail. Consistent with our 
previous results, LEM2 was found to interact with A-type Lamins in a direct manner in blot 
overlay and microtiter assays (Fig. 30). Interestingly the affinity for disease-causing Lamin A 
mutants R527P and L530P, both causing Emery-Dreifuss Muscular Dystrophy, was reduced as 
compared to wild-type Lamin A or Lamin A mutants causing other forms of laminopathies, i.e. 
“R482Q” (causing Familial Partial Lipodystrophy) and “E578V” (causing Hutchison Gilford 
Progeria) (Fig. 30).  
    
Figure 30: Direct binding of LEM2 fragments to lamins tested by microtiter and blot overlay 
assays. (A) Microtiter assay. Recombinant purified pre-Lamin A tail, Lamin B1 tail or purified 
BSA were immobilized in microtiter wells, incubated with equimolar amounts of 35S-labeled 
LEM2-full length (FL), N-terminus of LEM2 ΔLEM (NΔLEM) or LEM2-C-terminus (C), then 
washed and counted (n=3 triplicate sets). Bars indicate standard deviations. (B) Blot overlay 
assays. Purified recombinant pre-Lamin A tail, Lamin C tail, pre-Lamin A tails containing 
single-point disease mutations R482Q, R527P, L530P, E578V, Lamin B1 tail, C-terminus of 
MAN1 (M-C) and Emerin mutant Δ95 (lacking residues 95-99; Δ95) were resolved in triplicate 
via SDS-PAGE: Two membranes were probed with either 35S-LEM2 or 35S-LEM2-C-terminus 
and autoradiographed (upper and middle panels), and a third gel was stained with Ponceau S 
(lower panel). Experiment was carried out by M. Mansharamani & K. Wilson (Baltimore, USA). 
 
Additionally, these experiments revealed a second so far unknown Lamin-interacting region 
within the LEM2 C-terminus. Unexpectedly and contradicting our previous results, LEM2 bound 
Lamin B in these assays, though with about 30% reduced efficiency. Our previous experiments 
indicated an association of LEM2 with other LEM proteins of the INM, i.e. Emerin and MAN1 
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(Brachner et al. 2005). These interactions were confirmed in the in vitro binding experiments, 
revealing a direct interaction of LEM2 with MAN1 C-terminus (Fig. 29) and Emerin (Fig. 31).  
 
Figure 31: Crude lysates from bacteria expressing either wild type (WT) or disease mutant 
emerin proteins S54F, Q133H and P183H were resolved by SDS-PAGE, transferred to 
membrane and either probed with 35S-LEM2-FL or stained with Ponceau to control for the 
amount of recombinant emerin protein in each lane. Experiment was carried out by 
M. Mansharamani & K. Wilson (Baltimore, USA). 
 
Intriguingly LEM2 did not bind to the Emerin mutants “Δ95” and the disease causing mutation 
“Q133H” whereas disease-linked Emerin mutations “S54F” and “P183H” did not affect LEM2 
binding (Fig. 30), clearly indicating a specific interaction between both proteins. 
 
Summary and Conclusions 
In this study, we aimed at investigating the role of LEM2’s individual domains and the effects of 
ectopic expression of various LEM2 fragments on proposed LEM2 binding partners and on the 
cell cycle. Interestingly, we observed a subtle redistribution of Lamin A/C from the NE to the 
nucleoplasm upon expression of a LEM2 N-terminal fragment and an impairment of cell cycle 
progression. We speculate that these two effects are causally connected, because Lamin A/C has 
been linked to various cellular processes affecting proliferation. It is known for a long time that 
Lamin A/C is linked to differentiation but the molecular mechanisms remain unknown (Rober et 
al. 1989; Stewart and Burke 1987). Despite the putatively central function of Lamin A/C in 
differentiation, lmna deficient mice do not exhibit a severe deleterious phenotype until birth 
(Sullivan et al. 1999). Hence Lamin A/C is likely not essential for differentiation during 
development, but is probably involved in the establishment and maintenance of a fully 
differentiated phenotype in certain cell types during postnatal tissue homeostasis (Peter and Nigg 
1991). Interestingly, the subnuclear distribution of Lamin A/C changes from a more 
nucleoplasmic to a mostly peripheral localization during differentiation of cells as described in 
myogenic and myelogenic in vitro differentiation models (Collard et al. 1992; Muralikrishna et 
al. 2001). LEM2 expression in muscle differentiation was also investigated in a study by Chen 
and colleagues, who reported that LEM2 (synonymously: NET25) is upregulated during C2C12 
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myoblast differentiation (Chen et al. 2006) – an effect which was never observed in our own 
experiments using a C2C12 clone in the lab (data not shown). In contrast, we noticed an 
inhibition of myoblast differentiation upon stable overexpression of LEM2 in C2C12 cells, 
probably pointing to an interference with cell cycle exit, consistent with the observed cell cycle 
phenotype of LEM2 overexpressing HeLa cells (described in this chapter). 
It remains unclear, however, whether the increase of nucleoplasmic Lamin A/C triggered by 
overexpression of LEM2 N-terminus lead to cell death. Theoretically, this phenomenon could be 
caused by a checkpoint mechanism initiating cell cycle arrest, and finally apoptosis or necrosis. 
However, overexpression of LEM2-NT did not cause cell cycle exit as indicated by the positive 
Ki-67 staining and BrdU incorporation. Alternatively, competition of LEM2-NT with 
endogenous LEM2 at the NE and subsequent dislocation to the ER (as observed for ectopic 
full-length LEM2) could trigger cell cycle checkpoints and cause the observed effects. 
In contrast to the effects observed upon expression of LEM2 fragments, we found higher 
proliferation rates in HeLa and C2C12 cells overexpressing full-length LEM2, and a mild shift of 
nucleoplasmic Lamin A/C to the periphery. In accordance with our results, Ulbert and colleagues 
have shown that knock-down of LEM2 impairs cell proliferation (Ulbert et al. 2006) and slightly 
delays cell cycle in G2 phase, although the authors did not comment whether cells additionally 
underwent apoptosis or necrosis.  
Overall, the establishment of stable cell lines expressing LEM2 deletion constructs was 
inefficient, as compared to full-length LEM2 - most likely due to competition with endogenous 
LEM2 functions in nuclear architecture and cell cycle control. The observation that the lack of 
either the LEM or the MSC domain, thereby representing a membrane anchored LEM2 
construct, negatively affected cell proliferation, while full-length LEM2 activated proliferation, 
pointed towards an important contribution of these domains to LEM2 function. The LEM 
domain could exert this function via binding BAF, which is involved in chromatin organization 
and gene expression (Margalit et al. 2007a). Intriguingly, BAF was recently reported to 
relocalize from the nucleoplasm to the cytoplasm in senescent or non-cycling cells, indicating a 
role of BAF in proliferation (Haraguchi et al. 2007). The MSC domain was found to be 
responsible for the formation of LEM2 patches at the NE, which recruit various resident proteins 
of the NE and the nuclear lamina together with chromatin. Thus, the impact on proliferation 
could be indirect by affecting other INM proteins, some of which are known to interfere with 
signaling pathways: MAN1 was shown to tether Smad proteins at the NE (Bengtsson 2007; Pan 
et al. 2005); Emerin was reported to regulate nuclear β-Catenin activity (Markiewicz et al. 
2006).  
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The INM protein LBR (Lamin B-Receptor) has been shown previously to localize in 
microdomains along the NE, where it was suggested to form large assemblies of heterochromatin 
(Makatsori et al. 2004). We did not observe any overlap of LBR and LEM2 in 
immunofluorescence (Brachner et al. 2005). Hence, we propose Lamin A/C dependent 
complexes formed by LEM2 at the nuclear periphery including INM proteins, BAF and 
chromatin, which are clearly distinct from the microdomains formed by LBR. 
 
Materials & Methods  
Cloning strategy and plasmids 
The eukaryotic expression vector pTB-hLEM2 has been described previously (Brachner et al. 
2005). LEM2 fragments hLEM2-NT, hLEM2ΔLEM, hLEM2ΔMSC, hLEM2ΔLEMΔMSC were 
constructed by cloning PCR-generated sequences into pEntry-D-Topo vector (Invitrogen) via 
Topoisomerase reaction according to the recommendations of the manufacturer. Subsequently 
the fragments were shuttled into pDEST51 vector using Invitrogens’ Gateway® technology as 
described before (Brachner et al. 2005). PCR primers used were: 
hLEM2-139 forw 5’-CACCGCCATGGAGGAGCGGCTGCGGGAG-3’ and hLEM2-SEX rev 
5’-GCATCGCTCTGAGTCAGAGAAGGAAGAGG-3’ to generate hLEM2ΔLEM, hLEM2-
ATG forw 5’-CACCATGGCCGGCCTGTCGGACCTGGAACTGCGGC-3’, hLEM2-1236 rev 
5’-ATACATGGCTTGTTCCTCCTCTTC-3’ for hLEM2ΔMSC as well as hLEM2-139 forw and 
hLEM2-1236 rev for hLEM2ΔLEMΔMSC. 
LEM2 N-terminal fragment, LEM2-NT, was cloned accordingly: Primers hLEM2-ATG forw 
and hLEM2-585 rev 5’-AAGCTTCGCGCCAGCAGGGCCCGCTCGAGT-3’ were used to 
generate the fragment, which was ligated into the pEntry-D-Topo vector. From the resulting 
pEntry-hLEM2-NT vector, the fragment was shuttled into either the pTracer or the pCDNA-myc 
plasmid (Invitrogen). 
 
Cell culture, Transfection, Clonal Selection & Growth curves 
HeLa cells were cultivated and transfected as described previously (Brachner et al. 2005). Clonal 
selection for stable expression of ectopic proteins was done after transfection by seeding of 
single cells and addition of the antibiotic Blasticidin (Invitrogen) to the growth medium 
(20µg/mL) for two weeks. Single colonies were picked using cloning cylinders and expanded for 
further analysis. Growth curves were determined by seeding of 105 cells to petridishes (6 cm 
diameter) at day 0 and counting of total cell numbers in one petridish each day. Cell counting 
was done with a “Casy Cell Counter” (Casy). Curves were plotted using “Excel” (Microsoft). 
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Immunofluorescence microscopy & BrdU incorporation assay 
Fixation and staining procedures were done as described previously (Brachner et al. 2005). 
Antibodies used for staining were mouse and rabbit anti-V5 (Invitrogen and Sigma, 
respectively), a BAF antiserum was kindly provided by K. Furukawa (Furukawa 1999), sera 
against LAP2α and LAP2β have been described previously (Dechat et al. 1998; Vlcek et al. 
2002). Anti-Lamin A (clone 133A2) was purchased from Abcam, the monoclonal antibody 
against Lamin A/C was generously provided by F. McKeon (Loewinger and McKeon 1988) and 
the mouse anti-Lamin B1 antibody (8D1) was a kind gift of D. Vaux (Maske et al. 2003). 
BrdU labeling was performed using the “BrdU labeling and detection kit I” (Roche), essentially 
according to the manufacturers manual. Briefly, cells were seeded on cover slips the day before 
labeling at various densities, transfected with Lipofectamine 2000 (Invitrogen) following the 
manufacturers instructions and BrdU labeled for 30 min the following day. After the incubation 
time, cells were fixed with ice-cold EtOH/50mM Glycine pH2.3 at -20°C for 20 min, followed 
by standard immunofluorescence staining procedures. Cells positive for BrdU incorporation 
were counted and numbers were compared to untransfected cells in the same culture and to 
untreated control cells. 
- 71 - 
 
3.2.3 Yeast SRC1 (HeH1) and Human LEM2 are Orthologous Proteins  
          with Functional Conservation Throughout Evolution 
The nucleus represents the most prominent feature of eukaryotic cells and is separated from the 
cells’ cytoplasm by a lipid bilayer, the nuclear envelope (see also chapters 2.1 and 2.2). Despite 
the obvious structural similarities of the nuclear envelope (NE) and nuclear pore complexes 
(NPCs) in unicellular organisms, such as S.cerevisiae, and in higher eukaryotes, little is known 
about functional conservation of specific constituents of the NE. 
The starting point of this study was a computational analysis of genomic databases aiming at the 
identification of genes orthologous to human LEM2 in other species. Surprisingly we retrieved a 
putative ortholog in S.cerevisiae with significant similarities in primary sequence and in domain 
topology. Consequently, we intended to investigate the phylogenetic relationship of the 
mammalian inner nuclear membrane protein LEM2 and its proposed orthologous protein in 
yeast, SRC1, on a functional level, exploiting a collaboration with Susana Rodriguez-Navarro 
(Centro de Investigación Príncipe Felipe, Valencia, Spain), who has described a SRC1-/- yeast 
strain previously (Rodriguez-Navarro et al. 2002). 
 
Results 
Comprehensive searches for LEM2-related sequences in genomic databases revealed the yeast 
gene SRC1 (or HeH1 according to a different nomenclature) (King et al. 2006) as a putative 
orthologous protein to human LEM2 or MAN1 (see also chapter 3.1). Besides S.cerevisiae, also 
several other unicellular organisms contain this conserved gene, suggesting a strong functional 
conservation of the protein throughout evolution. All so far available sequences share a common 
domain topology including a N-terminal SAP or LEM motif, two transmembrane domains as 
well as the highly conserved C-terminal MSC domain (Fig. 32). In a recent study, King and 
colleagues (King et al. 2006) concluded that the yeast proteins HeH1 (synonymous to SRC1) and 
HeH2 are orthologous to mammalian LEM2 and MAN1. Furthermore, a detailed computational 
study performed by Mans and colleagues also proposed that MAN1 and SRC1 proteins are 
evolutionary conserved INM proteins (Mans et al. 2004). 
In order to analyze the evolutionary relationship of the SRC1 family and the LEM2/MAN1 
family we performed comprehensive sequence alignments and calculated the similarities of the 
two important motifs within these proteins, the SAP/LEM and the MSC domain. As the major 
difference between SAP and LEM domain is the direct versus indirect way to interact with 
chromatin we included the LEM-like motif of human LAP2, representing a related, proposed 
direct DNA binding motif (see also chapter 3.1) in the analysis. 
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Figure 32: Predicted domain topology of metazoan LEM2 proteins and of orthologous proteins 
in unicellular eukaryotes. 
 
Interestingly, all analyzed SAP motifs, which are thought to resemble a helix-extension-helix 
structure (therefore sometimes designated as “HeH” motif) are significantly more closely related 
to the LEM-like motif than to the canonical BAF-interacting LEM domain. Whereas the 
similarity between the LEM domain and SAP-like motifs did not exceed approximately 30% at 
primary sequence level, the conservation to the LEM-like motif was up to 52% (Fig. 33). The C-
terminal MSC motif, reported to form a winged-helix DNA binding motif (Caputo et al. 2006), 
was found to be well conserved among human LEM2/MAN1 and its orthologous proteins in 
protozoan organisms, accomplishing about 40% of similarity at amino acid level (Fig. 33). 
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Figure 33: Conservation of the LEM/SAP domain and the C-terminal MSC domain among the 
SRC1 protein family. Abbreviations of species as indicated in Figure 31. 
 
Therefore, we speculate that the evolutionary conserved LEM2/MAN1/SRC1 protein 
organization may have essential functions, probably in organizing peripheral chromatin. 
Starting from a mild phenotype in sister chromatid segregation in src1-/- yeast cells, Rodriguez-
Navarro and colleagues tested for synthetic interactions between various mutants known to be 
involved in sister chromatid segregation and SRC1. While no additional phenotype was observed 
in case of cdc20-/-src1-/- (Cdc20 ubiquitinates Securin to liberate Separin which then is able to 
cleave Cohesin. After Cohesin cleavage, sister chromatid segregation is initiated.), both esp-/- 
and scc-/- (encoding yeast Separin and Cohesin respectively) failed to grow without SRC1, 
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thereby clearly suggesting a role of SRC1 in chromatid segregation (Rodriguez-Navarro et al. 
2002). In order to confirm the existence of an evolutionary conserved molecular function of 
LEM2 and SRC1 on a genetic level directly, human LEM2 was tested for functional 
complementation capacity in the temperature-sensitive esp-/-src1-/- yeast strain. 
Ectopic overexpression of human LEM2 and MAN1 in yeast cells was verified by Western blot 
analysis on protein level (Fig. 34A) and intracellular localization was tested by fluorescence 
microscopy in living cells (Fig. 34B). We concluded from these initial experiments that ectopic 
expression of LEM2 is not detrimental to yeast cells, as strong expression levels of the 
LEM2-V5 construct were achieved in yeast. MAN1 was expressed only at low levels, probably 
due to toxicity (Fig. 34A). Intriguingly, fluorescence microscopy revealed that human LEM2-
RFP is recruited to the yeast NE, although the nuclei of unicellular eukaryotes contain no nuclear 
lamina (see also chapter 2.3). Whether the LEM2-RFP construct localizes at the inner or outer 
nuclear membrane could not be determined. Recently King and colleagues proposed an NLS in 
INM membrane proteins targeting these proteins to the INM (King et al. 2006). As two predicted 
NLS were also present in human LEM2, they may mediate the targeting of LEM2-RFP to the 
yeast INM. The localization of hLEM2 at the yeast NE could be further stabilized by the MSC 
domain, which may interact with peripheral chromatin. The LEM domain is supposed to be 
inactive in yeast due to the lack of a BAF ortholog in yeast (Margalit et al. 2007a), but the 
existence of so-far unknown interaction partners can not be excluded.  
              
Figure 34: (A) Human LEM2 and MAN1 ectopically expressed in yeast. Left image: Ponceau-
stained Western blot of yeast extract, right image: the same blot probed with anti-V5 antibody. 
Control: untransformed cells. Arrows: Expressed V5-tagged proteins at correct heights. (B) 
Confocal fluorescence image of living yeast cells transformed with hLEM2-RFP. Arrow: Yeast 
NE.  
A B 
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The results of the complementation assays showed that both, SRC1 and human LEM2 were able 
to complement the growth phenotype as compared to empty vector controls (Fig. 35A). This 
clearly indicates the postulated phylogenetic relationship of mammalian LEM2 proteins and 
yeast SRC1, not only at the level of sequence conservation, but also functionally. To further 
elaborate the domains of LEM2 involved in complementation, we tested two LEM2 deletion 
constructs. Intriguingly, the MSC domain of LEM2 as well as the insertion of the construct into 
the membrane was found to be essential for complementation, as the constructs hLEM2ΔMSC 
and hLEM2ΔTM failed to complement the esp-/-src1-/- growth phenotype. The unrelated human 
NE protein Nurim and an empty control vector were used as negative controls (Fig. 35A). 
Additionally, we tested for complementation ability of human MAN1 (Fig. 35B), but the results 
are still unclear as the complementation was much weaker compared to hLEM2 and the 
expression level of MAN1 in yeast remained very low for unknown reasons.  
 
 
Figure 35: Complementation assay in a esp-/-src1-/- temperature sensitive yeast strain. Lanes 1: 
Growth at permissive temperature. Lanes 2 and 3: Growth at restrictive temperature, two 
different time points. (a) Yeast transformed with empty control vector (control) or expression 
vectors containing SRC1 or human LEM2. (b) Yeast transformed either with empty control 
vector (control) or with expression vectors containing either human LEM2 constructs (as 
depicted at the right hand side), human MAN1 or Nurim. Right hand side: Schematic LEM2 
constructs: Orange rectangle: LEM domain, red: transmembrane domain, violet: MSC motif. 
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Nonetheless our data show for the first time the functional conservation of a yeast NE protein 
throughout evolution, and we could narrow down one functionally relevant region to a specific 
domain present in SRC1 and LEM2, representing a C-terminal DNA binding motif (Caputo et al. 
2006). These conserved functions of the proteins may include roles in NE integrity, in 
organization of chromatin at the nuclear periphery, or in cell cycle control (see also previous 
chapters of this thesis). Also a function in sister chromatid segregation might be envisaged, 
considering the genetic link to src1 mutants and our observation of linked nuclei of adjacent 
hLEM2-overexpressing cells after mitosis. 
 
Summary & Conclusions 
LEM2/MAN1 and SRC1-like proteins form an evolutionary conserved family of INM proteins, 
as it was suggested in several reports before (Brachner et al. 2005; King et al. 2006; Mans et al. 
2004). These conclusions were solely on computational prediction. We have shown the 
phylogenetic relationship in vivo by genetic means directly. 
The functional conservation of LEM2 throughout evolution is proposed by several findings.  
(1) Ectopic human LEM2 was targeted to the NE in yeast cells. (2) Complementation assays in a 
esp-/-src1-/- yeast background revealed that human LEM2 partially compensates the growth 
phenotype caused by the lack of yeast SRC1. Based on the analysis of various LEM2 deletion 
constructs we propose an essential role of the interaction of the MSC motif with DNA. It remains 
unclear whether LEM2/SRC1 fulfils specific roles in the structural organization of the nuclear 
 
Figure 36: Summary of proposed SRC1 
interactions. Adapted from the “STRING” 
database (http://string.embl.de/). 
periphery in the interphase nucleus or whether 
it is involved in mitosis as suggested by data 
obtained from src1-/- cells (Rodriguez-Navarro 
et al. 2002). Interestingly, proteomic screens 
employing the yeast-two-hybrid technology, 
identified SRC1 to interact with a component 
of the GINS-complex, which might be 
involved in DNA replication (MIPS database, 
http://mips.gsf.de/genre/proj/yeast/) (Ito et al. 
2001; Labib and Gambus 2007) and with 
several other nuclear components, including 
MCD1, a protein involved in sister chromatid 
cohesion, the cyclin dependent kinase CDC28 
and components of the chromatin remodeling
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complex SWR1 (Fig. 36). The interaction with chromatin via N-and C-terminal domains may be 
a common, evolutionary conserved property of all LEM2/MAN1 and SRC1-like proteins, 
although the molecular function of this “forceps”-type binding to DNA has still to be 
determined. The “replacement” of the N-terminal SAP motif by a LEM domain during evolution 
might reflect the evolutionary force to increase the complexity of regulation of the chromatin-NE 
interactions in metazoan organisms. This was achieved by introducing a “novel” mediator 
protein that regulates the binding of the LEM domain to chromatin. Noteworthy, a recent study 
performed by Hattier and colleagues revealed interesting findings upon overexpression of HeH1 
and HeH2 in yeast. The authors demonstrated that excess of HeH1 and HeH2 perturbs the yeast 
NE, is highly toxic to cells and distorts the chromatin organization, thereby corroborating a 
proposed function of both proteins in NE structure and chromatin organization (Hattier et al. 
2007).  
In C.elegans, knock-down of ce-LEM2 or ce-Emerin alone had no dramatic effect on cell 
viability (about 15% dead embryos), whereas the knock-down of both membrane anchored LEM 
proteins was detrimental for almost 100% of embryos (Liu et al. 2003), strongly suggesting 
redundant functions of these INM proteins. Saccharomyces cerevisiae contains a second related 
gene, encoding a currently undescribed protein, termed HeH2 (or YDR458) (King et al. 2006; 
Rodriguez-Navarro et al. 2002), as well as a shorter splice variant of HeH1, which lacks the C-
terminal transmembrane domain and the MSC motif (Fig. 37). 
 
Figure 37: Predicted domains in yeast Helix-extension-Helix proteins 1 and 2. Yellow rectangle: 
SAP-like motif, blue box: Chromo-Domain, red: transmembrane domains, violet: MSC domain. 
 
In analogy to C.elegans, HeH1 (SRC1) and HeH2, may have redundant functions in yeast, 
although no evidence for a functional redundancy was reported so far by Rodriguez-Navarro and 
colleagues (Rodriguez-Navarro et al. 2002). Nevertheless, it would be very exciting to 
investigate heh1-/-heh2-/- double knockout cells and to combine heh1 or heh2 deficiency with esp 
or scc knockouts. Currently these experiments are planned by our collaborators and will 
probably provide deeper insights into the functions of the LEM2/SRC1 superfamily. 
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Materials & Methods 
Cloning strategy and plasmids 
The yeast expression vectors containing hLEM2, hLEM2ΔMSC, hLEM2ΔTM, hMAN1 were 
cloned by digesting the mammalian expression vectors “JG132” (full length hLEM2), “AB82” 
(hLEM2ΔMSC), “JG187” (hLEM2ΔTM) and “AB46” (hMAN1) with restriction enzymes SpeI 
and PmeI, thereby retrieving fragments containing the respective inserts fused to the 6xHis and 
V5-tag of the pTracer vector. Fragments were gel eluted and ligated into the SpeI/SmaI sites of 
the yeast expression vector p416-GPD plasmid. Human Nurim was amplified by PCR from a 
human mixed tissue cDNA sample.  
Primers used were hNurim-forw 5’-CAGGAATTCATGGCCCCTGCACTGCTC-3’ and  
hNurim-rev 5’-TATGTCGACTCACTCTGCCTCCCCATCC-3’, the fragment was digested with 
EcoRI and SalI, and ligated into the corresponding sites of p416-GPD. The RFP-tagged hLEM2 
was cloned by inserting the PCR generated and SpeI/XhoI cut monomeric RFP (Long et al. 
2005) into the XbaI and SalI sites of p416-hLEM2.  
Primers used were mRFP-forw 5’-GTCGACTAGTCATGACTGGTGGACAGCAAATG-3’ and 
mRFP-rev 5’-GTATCTCGAGTTAGGCGCCGGTGGAGTG-3’)  
 
Computational Analysis 
In-silico analyses of sequences as well as computational prediction of protein motifs were 
performed essentially as described previously (Brachner et al. 2005). Sequence alignments and 
calculation of consensus sequences were done with the ClustalW software 
(http://www.ebi.ac.uk/Tools/clustalw). 
 
Live-cell fluorescence microscopy 
Yeast cells were transformed with the p416-hLEM2-RFP construct and selected for uracil 
independent growth. For fluorescence microscopy living cells were distributed in ibidi-treat® 
slides (ibidi) and imaged on a LSM-Meta confocal laser scanning microscope (Zeiss). Images 
were adapted for brightness and contrast using the Zeiss LSM Image Browser (Zeiss) and 
mounted with programs Photoshop and Illustrator (Adobe). 
 
Immunoblotting 
Cell lysis, PAGE and immunoblotting were performed as described previously (Brachner et al. 
2005).  
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3.2.4 LEM2, Conclusions & Outlook 
Biochemical analyses revealed that LEM2 is a novel LEM protein at the INM which is 
associated with A-type Lamins (Brachner et al. 2005). Subsequent studies reported (1) that 
LEM2 is upregulated during myodifferentiation (Chen et al. 2006), (2) that LEM2 is essential for 
the maintenance of the nuclear shape in human cells (Ulbert et al. 2006) and (3) that LEM2 
represents an evolutionary conserved gene with orthologs in unicellular organisms (Brachner et 
al. 2005; King et al. 2006; Mans et al. 2004) (chapter 3.1). Recently, we could show that LEM2 
was conserved throughout evolution not only by sequence and domain topology of but also by 
localization at the NE and its particular functions (chapter 3.2.3). Conserved LEM2 functions 
may include the structural organization of the NE, chromatin organization at the nuclear 
periphery, as suggested by proposed HeH1 (SRC1) binding partners and observations upon 
overexpression of HeH1 and HeH2 ((Hattier et al. 2007) and chapter 3.2.3), and a role in sister 
chromatid segregation, based on the reported phenotype of src1-/- yeast cells (Rodriguez-Navarro 
et al. 2002). Intriguingly, human LEM2ΔMSC did not rescue the growth phenotype of 
esp-/-src1-/- deficient yeast (chapter 3.2.3) pointing to a direct link between LEM2 functions and 
MSC domain indicated chromatin organization. 
MAN1, another LEM domain protein at the INM, is closely related to LEM2 regarding sequence 
and domain topology. Both proteins bind directly to A-type Lamins, BAF and Emerin (Brachner 
et al. 2005; Mansharamani and Wilson 2005), and we could show that they also interact with 
each other in vitro (chapter 3.2.2). However, also non-redundant functions of both proteins were 
described. The most characteristic property specific for MAN1 is the direct binding to Smads via 
its unique C-terminal “RRM” motif, which is missing in LEM2 proteins (Brachner et al. 2005; 
Pan et al. 2005). This finding raises the question whether LEM2 might act as a negative 
regulator of MAN1 functions by competitive binding to Lamin A/C, Emerin and BAF. 
Overexpression of full-length LEM2 in cells revealed an interesting role of the C-terminal 
winged-helix type DNA binding motif identified originally by Caputo and colleagues in MAN1 
(Caputo et al. 2006), and termed MSC domain in LEM2 (Brachner et al. 2005; Mans et al. 
2004). The analyses of various deletion constructs showed that the MSC motif is essential for the 
formation of LEM2 patches at the NE (chapter 3.2.2). Holaska and colleagues purified several 
distinct Emerin-containing NE complexes from HeLa cells, proposing that each complex is 
involved in a specific nuclear process (Holaska and Wilson 2007). Schirmer and Gerace 
suggested that INM proteins form tissue specific complexes with other INM proteins, 
transcription factors and chromatin at the INM. They argue that these platforms are essential to 
establish and maintain the differentiated state of specific cells (Schirmer and Gerace 2005).  
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Interestingly, expression of N-terminal LEM2 fragments, which contain the Lamin A/C-
interacting region of LEM2 lead to a subtle relocalization of peripheral Lamin A/C to the 
nucleoplasm. Expression of these constructs in cells inhibited cell cycle progression but did not 
induce quiescence or senescence (chapter 3.2.2). A cell cycle defect was reported also upon 
RNAi-mediated down regulation of LEM2 in cells (Ulbert et al. 2006). A possible explanation 
for these findings may be that a lack of LEM2 at the INM or the overexpression of LEM2 
N-terminal fragment triggers a checkpoint mechanism mediated by an excess of nucleoplasmic 
Lamin A/C. 
Although a striking cellular phenotype was reported upon downregulation of LEM2 in cell lines 
(Ulbert et al. 2006), it seems problematic to me to engineer a LEM2-deficient mouse model as 
its functions might be compensated by other INM proteins, especially by MAN1. Functional 
compensation was observed in a emerin-/- mouse (Lammerding et al. 2005) as well as in lem-2 
deficient C.elegans (Liu et al. 2003).  
 
LEM proteins have multiple functions in cell structure, chromatin & signaling 
Metazoan organisms, including unicellular species, contain complex, intricate networks of 
molecular switches, signal transducers and building blocks, in which resident proteins often have 
(1) a multitude of interaction partners and (2) often fulfill more than a one function. Not 
surprisingly, both, a plethora of interacting molecules and several (partially redundant) functions 
were found for the nuclear Lamins and the LEM protein family. The nuclear lamina and LEM 
proteins at the INM have essential functions in the maintenance of nuclear shape and nuclear 
positioning within the cell, exert essential roles in chromatin organization at the nuclear 
periphery and modulate specific signaling pathways. Accordingly, various and often mosaic 
phenotypes are observed in envelopathy patients bearing mutated versions of these proteins. 
Hence, the pathological phenotype reflects the role of these proteins in nuclear structure, 
chromatin organization and signaling.  
LEM proteins and INM proteins may function as integration platform, connecting the 
cytoplasmic cytoskeleton with a proposed nucleoskeleton. They may also recruit transcription 
factors and signaling molecules and tether chromatin to the nuclear envelope. Therefore, the 
nuclear periphery represents not only a structural enforcement between cytoplasm and nucleus, 
but provides an integrative interface to convert and execute signals from in-and outside the 
nucleus. The family of LEM proteins exhibit many features allowing them to fulfill such a 
multitude of integrative functions: INM localization, binding partners (as identified so far), 
ability to interact with chromatin and potential involvement in signaling pathways. 
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3.3 LEM3 
The LEM3 sequence has been annotated in several computational screens aiming to identify 
novel members of the LEM-domain containing-, Ankyrin repeat containing-, or GIY-YIG 
protein family (chapter 3.3.1). In this study we identified LEM3 as a novel, highly conserved 
LEM protein, present in all investigated species from C.elegans to man.  
Analyses of the expression pattern revealed that LEM3 is transcribed in a tissue-restricted 
manner, indicating a function in lymphoid cells. Furthermore, the LEM3 sequence was found to 
be subjected to alternative splicing, yielding three different isoforms. Intriguingly, two isoforms 
lack half of the LEM domain as well as varying parts of the predicted C-terminal GIY-YIG 
motif, suggesting regulatory functions of the full-length protein.  
Ectopic expression of GFP-or V5-tagged human LEM3 revealed a cytoplasmic localization and a 
significant association with Actin filaments, as well as γ-Tubulin. Artificial inhibition of nuclear 
export by administration of Leptomycin B leads to a strong accumulation of LEM3 in the 
nucleus, indicating nucleo-cytoplasmic shuttling of LEM3. In contrast to human LEM3, murine 
LEM3 localized within both, cytoplasm and nucleus in untreated cells, but like hLEM3, mLEM3 
co-localized with Actin filaments and γ-Tubulin in the cytoplasm. Additionally, we found that 
nuclear LEM3 accumulated in speckles, which co-localized with splicing factor SC-35 and 
U snRNPs, suggesting a role in processing nucleic acids.  
The prediction of a GIY-YIG motif, a known structural domain involved in DNA cleavage and 
recombination, in LEM3 lead us to speculate about a possible function of LEM3 in DNA 
damage response. Therefore, we performed DNA damage experiments to elucidate any potential 
involvement of LEM3 in this particular cellular function. Surprisingly, we found that expression 
of LEM3 lead to a strong phosphorylation of DNA damage specific Histone H2A.X, irrespective 
of induced DNA damage. This effect was even more pronounced when human LEM3 was forced 
to accumulate in the nucleus by Leptomycin treatment. It remains unknown whether DNA 
damage and Histone H2A.X phosphorylation are direct consequence of LEM3 overexpression, 
probably due to the function of the GIY-YIG motif, or caused by an indirect mechanism, such as 
induction of apoptosis. 
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3.3.1 LEM3 (ANKRD41) is a Novel LEM-Domain Protein that Shuttles  
          between Nucleus and Cytoplasm and Affects BAF 
 
LEM3 (ANKRD41) is a novel LEM-domain protein that shuttles between 
nucleus and cytoplasm and affects Barrier-to-Autointegration Factor  
 
Andreas Brachner†, Ayelet Margalit*, Rachel Barkan*, Yosef Gruenbaum*, Roland 
Foisner†# and Josef Gotzmann†# 
 
Max F. Perutz Laboratories, University Departments at the Vienna Biocenter, †Department of 
Medical Biochemistry, Medical University of Vienna, and *Department of Genetics, The 
Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem 91904, Israel. 
 
Short title: Nucleo-cytoplasmic shuttling of LEM3 
 
Keywords: Barrier-to Autointegration factor, lamina, LEM-domain, nuclear transport,  
 
# Authors for correspondence:  
Roland Foisner 
Max F. Perutz Laboratories 
Medical University Vienna 
Dr. Bohr-Gasse 9 
A-1030 Vienna 
roland.foisner@meduniwien.ac.at 
 
Josef Gotzmann 
Max F. Perutz Laboratories 
Medical University Vienna 
Dr. Bohr-Gasse 9 
A-1030 Vienna 
josef.gotzmann@meduniwien.ac.at 
 
- 83 - 
 
Abstract  
The LEM domain is a 40 residues long structural motif that binds the chromatin-associated 
Barrier-to-Autointegration factor (BAF). Most of the characterized LEM-domain proteins reside 
in the inner nuclear membrane and bind lamins. Here we investigate a novel evolutionarily 
conserved LEM-domain protein lacking a transmembrane domain termed LEM3. Mammalian 
LEM3 encodes three alternatively spliced isoforms. The two smaller isoforms are missing part of 
the LEM-domain. Only the longest LEM3 isoform containing the complete LEM domain can 
bind BAF. Human LEM3 is mostly cytoplasmic and associates with actin stress fibers, while 
murine LEM3 localizes primarily to the nucleoplasm. Inhibition of nuclear export caused the 
accumulation of ectopically expressed human LEM3 in the nucleus and the mislocalization of 
BAF, suggesting that human LEM3 shuttles between nucleus and cytoplasm and interacts with 
BAF. RNA interference mediated knockdown in C. elegans showed that LEM-3 is not an 
essential gene and is not functionally redundant with the other C. elegans LEM proteins, LEM-2 
and Emerin.  
 
- 84 - 
 
 
Introduction 
The nuclear lamina is composed of lamins and lamin-associated proteins. It is positioned 
underneath the inner nuclear membrane (INM) and is involved in the dynamic organization of 
the nuclear envelope and peripheral chromatin (Foisner, 2001; Gruenbaum et al., 2005; Margalit 
et al., 2005b; Prunuske and Ullman, 2006; Schirmer and Foisner, 2007; Vlcek and Foisner, 
2007). Several INM proteins share an N-terminal-located structural motif of 40 amino acids 
length, termed the LEM domain (Laguri et al., 2001). LEM domain proteins have important and 
essential functions in regulating nuclear architecture and mitosis, and in cell signaling and gene 
expression (Margalit et al., 2005b; Wagner and Krohne, 2007). Mutations in human LEM 
proteins emerin, LAP2 and MAN1 cause human diseases affecting striated muscle and bone 
(Hellemans et al., 2004).  
One shared feature of all characterized LEM domain proteins is an interaction with a sequence-
independent DNA-binding and DNA-cross-linking molecule, termed Barrier-to-Autointegration 
Factor (BAF) (Cai et al., 2001; Margalit et al., 2007a; Shumaker et al., 2001), thereby 
establishing dynamic protein-chromatin interactions at the nuclear periphery. LEM protein - 
BAF complexes are involved in nuclear envelope assembly and chromatin re-organization after 
mitosis in C. elegans (Liu et al., 2003; Margalit et al., 2005a) and in mammalian cells (Dechat et 
al., 2004; Haraguchi et al., 2001; Shimi et al., 2004). Furthermore, LEM protein – BAF 
complexes were implicated in viral DNA integration into the host genome and in the regulation 
of gene expression (Margalit et al., 2007a).  
Apart from the well characterized LAP2, emerin and MAN1 other LEM genes have been 
identified and partially characterized: LEM2, a MAN1-related protein in mammalian cells 
(Brachner et al., 2005; Chen et al., 2006; Ulbert et al., 2006) and Otefin and Bocksbeutel in 
Drosophila (Padan et al., 1990; Wagner et al., 2004). The availability of the entire genome 
sequence of an increasing number of organisms allowed the in silico identification of several 
novel, so far uncharacterized putative LEM protein family members. In mammals these include 
LEM-domain-containing 1 (LEM5) (Lee and Wilson, 2004; Yuki et al., 2004), LEM3 and LEM4 
(Lee et al., 2000; Lee and Wilson, 2004). 
In this study we describe the initial biochemical and cell biological characterization of LEM3, 
which is the only so-far known LEM protein that is conserved from C. elegans to man. LEM3 
contains ankyrin repeats and has a centrally located LEM domain, but lacks a transmembrane 
domain. It shuttles between the cytoplasm and nucleus, binds BAF and affects BAF localization 
when overexpressed in cells.  
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RESULTS 
LEM3 is highly conserved in metazoans  
The LEM3 gene has been annotated previously in computational screens for novel protein family 
members characterized by the presence of a LEM-domain, ankyrin-repeats, or a GIY-YIG-motif 
(Dunin-Horkawicz et al., 2006; Lee et al., 2000; Lee and Wilson, 2004). All assembled LEM3 
sequences in the ENSEMBL database (http://www.ensembl.org /index.html), which are also 
annotated as ANKRD41 (Ankyrin repeat domain protein #41), reveal a putative LEM domain 
(Fig. 1A, red box) in the middle of the polypeptide (aa 342-385 in humans), 2-4 ankyrin repeats 
at the N-terminal domain depending on the species (green box, 3 repeats between aa 25-125 in 
hLEM3), and a putative C-terminal GIY-YIG motif (violet box, aa 431-601 in humans), which 
has also been described as B23131 in the Pfam-B database 
(http://www.sanger.ac.uk/Software/Pfam/) as a nucleases-specific domain potentially involved in 
DNA recombination and/or DNA repair (Dunin-Horkawicz et al., 2006). Human LEM3 
(hLEM3) contains 615 residues with a predicted molecular mass of 65 kD and a pI of 6.0, while 
murine LEM3 (mLEM3) is considerably smaller, comprising 534 amino acids with a predicted 
molecular mass of 56 kD and a pI of 6.2. Overall, primary sequence homologies between 
mammalian LEM3 proteins are around 54% with the C-terminal GIG-YIG domain showing the 
highest homology (~80%), while LEM3 orthologs in nematodes and arthropodes were 18% and 
23% identical to hLEM3 at primary sequence level, respectively (Fig. 1A). The molecular 
domain organization of LEM3 orthologs is conserved in representative organisms of major 
metazoan clades, including Vertebrata, Arthropoda, Tunicata, Nematoda and Echinodermata 
(Fig. 1B). This conservation has not been observed for other LEM proteins including Emerin, 
LAP2, MAN1, LEM2 and LEM5 (data not shown).  
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Fig. 1. LEM3 is an evolutionary conserved LEM-domain containing protein. (A) Comparison of 
the predicted domain organization of LEM3 orthologues from Homo sapiens (hs), Mus musculus 
(mm),  Rattus norvegicus (rn), Drosophila melanogaster (dm) and Caenorhabditis elegans (ce). 
Ankyrin repeats are shown in green, the LEM domain in red and a C-terminal domain of 
unknown function in violet. (B) Phylogenetic analysis of various LEM3 orthologues of major 
metazoan clades depicted as unrooted tree diagram. 
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LEM3 mRNA is alternatively spliced and expressed in a tissue-restricted manner 
Semiquantitative RT-PCR analysis of cDNAs derived from various human and mouse tissues, 
revealed highest expression levels of LEM3 mRNA in hematopoietic tissues including bone 
marrow, thymus and spleen (Fig. 2A). No or only low levels of LEM3 mRNA were detected in 
all other tested tissue samples (Fig. 2A). LEM3 is also highly expressed in cell lines derived 
from B-cell lymphomas (i.e. DAUDI, RAJI, RAMOS) and in a T-cell acute leukemia derived 
cell line (JURKAT), while no or only minor levels were detected in all investigated carcinoma-
derived cell lines, in an erythroleukemia cell line (K-562) (data not shown), in a plasma cell 
leukemia derived cell line (ARH-77) and in peripheral blood monocytes obtained from two 
healthy donors (PBM) (Fig. 2A). These results confirm data in the NCBI EST and Unigene 
databases (http://www.ncbi.nlm.nih.gov/), reporting hANKRD41 expression primarily in 
lymphoid tissues and lymphoma. Interestingly, expression of LEM3 was not found to be 
restricted to cells of the lymphoid lineage during murine embryonal development as fibroblasts 
derived from mouse and rat embryos showed moderate levels of LEM3 transcript. 
PCR analyses amplifying the 3’ half of the LEM3 cDNA from human and mouse  bone marrow 
cDNA libraries, produced a major DNA fragment of the expected size for a “full length” LEM3, 
as well as two minor smaller fragments in both human (Fig. 2B) and mouse samples (data not 
shown). Sequencing the smaller fragments revealed deletions of  75 or 264 base pairs, 
respectively, at position 1122 in the hLEM3 coding sequence. The longest transcript (termed 
LEM3α) was clearly the predominant isoform, while the two smaller isoforms, termed LEM3β 
and LEM3γ, were only weakly expressed. Interestingly, the smaller isoforms lack the second 
half of the LEM domain (LEM3β; Δ aa 375-400) or additionally parts of the common C-terminus 
(LEM3γ; Δaa 375-463). 
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Fig. 2. LEM3 is alternatively spliced and expressed in a tissue-restricted manner. (A) 
Semiquantitative RT-PCR analysis of LEM3 mRNA levels and of actin mRNA as control. 
B.Marrow (bone marrow), Sk.Muscle (skeletal muscle), PBM (peripheral blood monocytes). (B) 
DNA fragments of alternative LEM3 splice products were amplified by RT-PCR using primers 
shown in the schematic drawing, and analyzed by PAGE. B.Marrow (bone marrow).  
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Human and murine LEM3 have different cellular localization 
In order to determine the subcellular localization of LEM3α, we transiently expressed GFP- and 
V5-tagged versions of human and murine LEM3α in rat embryonic (oREC) cells. Interestingly, 
the localization of human and mouse LEM3α differed. Human LEM3α was localized 
predominantly in the cytoplasm, revealing a filamentous pattern in methanol fixed specimen, 
independent of the the nature, size and localization of the tag (Fig 3A). hLEM3β behaved like 
LEM3α (Fig.3, hLEM3β-V5), indicating that this localization does not require an intact LEM 
domain. The filamentous pattern of hLEM3α suggested colocalization with a major cytoskeletal 
network. Coimmunostaining analysis revealed that hLEM3α colocalized with the actin 
cytoskeleton, particularly with stress fibers, but not with microtubules or vimentin (Fig. 3B, C). 
Destroying actin filaments by Cytochalasin B treatment for 16 hours lead to aggregation of actin 
and reorganization of LEM3 (Fig. 3B). We concluded that hLEM3α associates with the 
cytoplasmic actin cytoskeleton. Similar results were observed for ectopically expressed murine 
mLEM3α (data not shown), although a major portion of mLEM3α accumulated in the nucleus 
(Fig. 3A, mLEM3-V5). The nuclear protein was distributed uniformly in the nucleoplasm and in 
speckle-type structures, where it colocalized with proteins involved in RNA-processing, 
including SC-35 and U-snRNPs (see supplementary Fig. 1A).  
The different localization of human and mouse LEM3α was an intrinsic property of the proteins 
and independent of the cell systems, since expression of human and murine LEM3α in other 
mouse (C2C12) or human cells (U2OS, MCF7) revealed identical results (data not shown). 
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Fig. 3.  Ectopic human LEM3α and β localize in the cytoplasm, while mouse LEM3 is 
predominantly nuclear. (A) oREC cells transiently expressing human V5- or GFP-tagged 
hLEM3α or β or mLEM3α were fixed and processed for immunofluorescence microscopy using 
antibodies to V5 (red) and DAPI to visualize DNA (blue). LEM3α-GFP was viewed directly. (B) 
Untreated oREC cells expressing human or mouse LEM3α were stained with V5 (green) and α-
Actin (red) antibodies as well as DAPI or oREC cells expressing LEM3α-GFP were treated with 
Cytochalasin (2µM for 16h), fixed and stained for α-Actin (red) and DNA (blue). (C) oREC cells 
expressing ectopic hLEM3-GFP or hLEM3-V5 were costained for α-Tubulin (red) or Vimentin 
(red) and DNA (blue). Confocal images are shown. Bars = 10µm. 
- 91 - 
 
hLEM3 shuttles between the nucleus and the cytoplasm  
Computational analyses revealed several putative nuclear export sequences (NES), as well as 
nuclear localization sequences (NLS) throughout hLEM3α (Fig. 4A), indicating that the protein 
shuttles between the nucleus and cytoplasm. To test this possibility, we treated hLEM3α 
expressing cells with Leptomycin B, a specific inhibitor of Crm-dependent nuclear export. 
Intriguingly, hLEM3α accumulated in the nucleus upon Leptomycin B treatment, often forming 
dot like structures in the nucleoplasm (Fig. 4B, supplementary Fig. 1B), indicating nucleo-
cytoplasmic shuttling of the protein.  
To investigate the contributions of different hLEM3α domains to nucleo-cytoplasmic shuttling, 
we tested the effect of Leptomycin B on the localization of expressed hLEM3α fragments. GFP 
fusions of C- or N-terminally truncated hLEM3α lacking the highly conserved GIY-YIG motif 
(ΔCT) or the ankyrin repeats (ΔANK), respectively, localized to the cytoplasm in the absence of 
Leptomycin B and accumulated in the nucleus in the presence of Leptomycin B, but did it less 
efficiently than full length LEM3α (Fig. 4B), suggesting that the C- and N-terminal domains of 
hLEM3α are both involved in the regulation of nucleo-cytoplasmic transport. The ectopically 
expressed LEM3α C-terminal fragment alone fused to GFP (CT), which has a molecular mass of 
52 kD and is thus unable to passively diffuse through nuclear pore complexes, localized 
exclusively to the nucleus independent of Leptomycin B confirming the existence of functional 
NLS within the C-terminus. In contrast, a central region of hLEM3α lacking both the N-terminal 
ankyrin repeats and the C-terminal GIY-YIG domain (ΔANKΔCT), was excluded from the 
nucleus in the absence of Leptomycin B and was only weakly, possibly involving passive 
diffusion, translocated to the nucleus in the presence of Leptomycin B. Therefore we concluded 
that a non-canonical nuclear export signal might be located between the N-terminal ankyrin 
repeats and the LEM domain.  
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Fig. 4. LEM3 is exported from the nucleus via a Crm-dependent pathway. (A) Localization of 
predicted NLS and NES signals in human (hs) and mouse (mm) LEM3α. Fluorescence analysis 
of  living oREC cells expressing GFP-hLEM3α and stained with DAPI before and after 
treatment with Leptomycin B (5 ng/mL for 3 hours). (B) Live cell imaging of oREC cells 
expressing various human LEM3-GFP deletion constructs or eGFP as negative control before 
(left column) and after 3 hours of Leptomycin treatment (right column). Cells were stained with 
DAPI to visualize DNA (blue). In drawings, ankyrin repeats are shown in green, the LEM3 
domain in red and the C-terminal motif in violet. Confocal images are shown. Bars, = 10µm. 
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LEM3 binds BAF and this binding requires an intact LEM domain  
Next, we investigated whether the LEM domain in LEM3α is able to interact with BAF, as 
previously demonstrated for all tested LEM domains (Dechat et al., 2004; Lee et al., 2001; 
Mansharamani and Wilson, 2005; Shumaker et al., 2001). Sequence alignments of the LEM 
domain of hLEM3α with those of other known human LEM proteins revealed that all residues 
previously identified by mutation analysis to be essential for BAF binding (Shumaker et al., 
2001) were highly conserved in hLEM3α (Fig. 5A, brown boxes). We performed co-
immunoprecipitation assays in order to test whether LEM3α and BAF are present in the same 
protein complex. Ectopically expressed V5-tagged human or mouse LEM3α or β isoforms were 
precipitated from cell lysates using anti-V5 antibodies, and the presence of BAF in the 
precipitate was tested by immunoblotting, using BAF antibodies. All ectopically expressed 
LEM3 proteins were efficiently precipitated by anti-V5 coupled protein G-beads (Fig. 5B, lower 
panel). Significant amounts of BAF co-precipitated with human and mouse LEM3α while 
hLEM3β, which misses part of the LEM domain, did not pull down BAF above background 
levels similar to control beads (Fig. 5B, upper panel, P-Co). hLEM2 used as a positive control 
pulled down BAF efficiently (Fig. 5B). Interestingly, precipitated BAF split up into three 
proteins with different molecular weights between 12 and 30kD. We speculate that formation of 
LEM-domain/BAF complexes may change BAF conformation (Forne et al., 2003) which are 
subsequently crosslinked by artificial oxidation during the precipitation procedure. These higher 
molecular weight complexes may not be destroyed during SDS-PAGE (also observed by (Dechat 
et al., 2004) (Zheng et al., 2000)). Recently it was also shown that monomeric BAF does not 
form complexes with the LEM motif (Cai et al., 2007). 
We concluded that LEM3α associates with BAF and that an intact LEM domain is required for 
that association.  
Despite the observed association of hLEM3α and BAF at biochemical level, 
immunofluorescence microscopy revealed mostly non-overlapping localization of hLEM3α and 
BAF in the cytoplasm and nucleus, respectively (Fig. 6, untreated). To test whether hLEM3α 
may affect BAF, when temporarily forced into the nucleus, we investigated BAF localization 
after treatment of hLEM3α-expressing oREC cells with Leptomycin B. Following Leptomycin B 
treatment for three hours, both hLEM3α and BAF were predominantly nuclear without any 
obvious effect on BAF distribution in ~50% of transfected cells (Fig. 6, normal phenotype). 
About 50% of transfected cells showed nuclear hLEM3α and a partial mislocalization of BAF to 
cytoplasmic aggregates, in addition to the nucleoplasmic distribution (minor delocalization 
phenotype). In contrast, non-transfected cells showed normal nucleoplasmic localization of BAF 
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after Leptomycin B treatment in ~95% of cases (Fig. 6, left graph), indicating that expression of 
hLEM3α combined with Leptomycin B treatment significantly affected BAF localization.  
We next released Leptomycin B treated cells from the drug, allowed the cells to recover for 
five hours in normal growth medium and tested BAF localization. This treatment produced three 
different localization patterns of BAF. Only <5% of transfected cells had normal nucleoplasmic 
distribution of hLEM3α and BAF, ~45% had partial delocalization of BAF to cytoplasmic 
aggregates (medium phenotype), and ~55% of cells had severe delocalization of BAF (strong 
phenotype) (Fig. 6). In the latter cells, hLEM3α localized to the nucleus and the cytoplasm, 
indicating that translocation of hLEM3α back from the nucleus to the cytoplasm following 
release of Leptomycin B treatment  caused redistribution of BAF. In the absence of ectopic 
hLEM3α expression BAF was unaffected and predominantly nuclear both in the presence of 
Leptomycin B or following its removal (Fig. 6, bar graphic) suggesting that BAF mislocalization 
is specifically caused by ectopically expressed hLEM3α. These data also confirm that hLEM3α 
and BAF can interact in vivo.  
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Fig. 5. LEM3 interacts with BAF in a LEM domain-dependent manner. (A) Sequence alignment 
of characterized human LEM proteins, indicating conserved residues in blue (conservative 
substitutions) or red (identical residues). Residues essential for BAF binding according to 
Shumaker et al. (Shumaker et al., 2001)(Shumaker et al., 2001)(Shumaker, Lee et al. 
2001)(Shumaker, Lee et al. 2001)(Shumaker, Lee et al. 2001)(Shumaker, Lee et al. 2001) are 
highlighted by coloured background. Amino acid positions in the protein sequence are indicated. 
(B) Expressed V5-tagged LEM2, hLEM3α and β and mLEM3 were immunoprecipitated from 
whole cell lysates using V5 antibodies and input, supernatant (SN-V5) and pellet (P-V5) 
fractions were analyzed by immunoblotting using antibodies to BAF (upper panel) and V5 (lower 
panel). P-Co shows control precipitates in the absence of antibodies. P fractions are 6 times 
more concentrated than SN and I fractions. Antibody control (Ab Co) shows 100ng of V5 
antibody. The relative amounts of BAF in V5- and control precipitates were measured by 
determining the intensity of bands using ImageQ., P (pellet), SN (supernatant). Note that only 
LEM isoforms with an intact LEM motif precipitate BAF. 
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Fig. 6. Expressed hLEM3 affects BAF localization upon transient nuclear accumulation. oREC 
cells expressing hLEM3α-V5 were treated with Leptomycin for 3 hours and released from the 
drug for 5 hours. Cells were fixed  at each time point and processed for immunofluorescence 
microscopy using antibodies to V5 (red), BAF (green) and DNA (blue). Confocal images are 
shown. Arrows indicate cytoplasmically mislocalized BAF. Bar, 10µm. Cells (n>200 each 
timepoint) were scored for medium or strong mislocalization of BAF and untransfected cells on 
the same plate were used as a negative control (normal). Bar diagram shows percentage of cells 
with “normal”, “medium” or “strong” BAF delocalization phenotype after 3 hours of 
Leptomycin treatment (left side) and after 5 hours of Leptomycin release (right side).  
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LEM-3 is not required for viability in embryos or adults 
Next, we aimed at testing the physiological relevance of hLEM3 function in vivo by RNA 
interference-mediated downregulation of LEM3 in mammalian cells. However RNAi turned out 
to be very inefficient in cells that express significant levels of endogenous LEM3 mRNA 
(JURKAT and RAMOS) due to unspecific, transfection-induced cell death and extremely low 
transfection efficiencies. We therefore switched to a different organism, C. elegans, where lem-3 
is expressed and RNAi mediated downregulation can be efficiently done (lem-3(RNAi)) (Lee, 
Gruenbaum et al., 2000). RT-qPCR analysis revealed that lem-3(RNAi) caused a significant 
reduction in lem-3 transcript levels (Fig. 7A, inset). We next examined animals with reduced 
levels of LEM-3 for any phenotype during development. We found that there was no increased 
embryonic lethality; lem-3(RNAi) embryos developed at normal rates into fertile adult nematodes 
with a normal brood size (Fig. 7A). These lem-3(RNAi) adults had no detectable phenotype, 
displayed normal feeding behavior, and produced viable fertile offspring as compared to control 
animals fed with L4440 feeding vector  (data not shown). Nuclear localization of other nuclear 
envelope proteins was not dependent on LEM-3. Neither the localization of Ce-lamin and Ce-
emerin nor that of GFP-BAF-1 (Margalit et al., 2007b) were affected by the knockdown of lem-3 
(Fig. 7B). We concluded that LEM-3 is not essential and is not required for the nuclear envelope 
localization of Ce-lamin, Ce-emerin or BAF-1. 
Given the functional redundancy, reported for the other two worm LEM-domain proteins, LEM-
2 and Ce-emerin (Liu et al., 2003), we tested the effect of lem-3(RNAi) on embryonic lethality 
and brood size of worms homozygous for deletion in emr-1 (VC237) or lem-2 (tm1582). 
Applying lem-3(RNAi) to the deletion strains had no affect on embryonic lethality (Fig. 7A) or 
the brood size of the adult animals, similar to RNAi with the L4440 control vector (data not 
shown). The strain homozygous for lem-2 deletion and heterozygous for the emr-1 deletion 
shows 70-80% embryonic lethality. Again, down regulating lem-3 did not increase embryonic 
lethality (Fig. 7A). We concluded that there is no obvious functional redundancy between LEM-
3 and the other C. elegans LEM domain proteins. 
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Fig. 7. Downregulation of lem-3 does not cause embryonic lethality in wildtype (N2), emr-1-
/emr-1- (emerin null), lem-2-/ lem-2- (LEM-2 null) or lem-2-/ lem-2-; emr-1-/+ (LEM-2 null and 
heterozygous for emerin) worms. Strains were fed with bacteria expressing either a control 
vector L4440 (blue) or lem-3 dsRNA (purple). The graph shows the percentage of embryonic 
lethality as Mean and SD. Insert shows RT-qPCR analysis of RNA from worms fed with control 
vector L4440 (L4) or lem-3. The carbonic anhydrase cah-3 gene was used as a control for RNA 
quality and amounts. RT-qPCR showed a significant reduction in lem-3 RNA levels following 
lem-3(RNAi). (B) Downregulation of LEM-3 did not affect the localization of Ce-lamin, Ce-
emerin, or GFP-BAF-1. Worms were fed with bacteria containing the L4440 vector (control) or 
lem-3(RNAi) and the offspring embryos were stained by indirect immunofluorescence using 
antibodies against Ce-lamin (Lamin) or Ce-emerin (Emerin). GFP-BAF-1 was viewed directly in 
live embryos. Bars = 5 µm.  
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Supplemental Fig. 1. LEM3 colocalizes with splicing speckles in the nucleus. (A) mLEM3-V5 
was expressed in oREC and cells were processed for immunofluorescence microscopy using 
antibodies to V5 (green), and either SC35 (red), U snRNPs (red) or hnRNP-A1 (red) and DNA 
(blue). (B) oREC cells expressing hLEM3-V5 were treated with Leptomycin for 3 hours, fixed 
and stained for V5 (green), U snRNPs (red) and DNA (blue). Confocal images are shown. Bars 
= 10µm. 
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Discussion 
The availability of whole genome sequences from many organism and improved computational 
tools have lead to the identification of novel putative LEM-domain proteins in various species, 
such as LEM3, 4 and 5 in mammals (Lee and Wilson, 2004; Yuki et al., 2004), and Bocksbeutel 
(Wagner et al., 2004) and Otefin (Padan et al., 1990) in Drosophila. Besides their common 
feature, the presence of a LEM motif and the interaction with BAF, many of the LEM proteins 
also have unique functions in chromatin organization, gene expression, and signaling (reviewed 
in (Schirmer and Foisner, 2007). LAP2β interacts with HDAC3 (Somech et al., 2007), emerin, 
MAN1, and LAP2α interact with transcription factors or repressors, such as GCL, Lmo7, Btf and 
Crx and Rb (Dorner et al., 2006; Haraguchi et al., 2004; Holaska et al., 2003; Holaska et al., 
2006; Mansharamani and Wilson, 2005; Melcon et al., 2006; Wilkinson et al., 2003), emerin and 
MAN1 bind to and affect β-catenin and Smad-signaling components, respectively (Markiewicz 
et al., 2006; Osada et al., 2003; Pan et al., 2005). Not surprisingly an increasing number of 
human diseases has been linked to genetic mutations in genes encoding LEM proteins in the past 
years (Vlcek and Foisner, 2007; Wagner and Krohne, 2007).  
In this report we describe the initial biochemical and cell biological characterization of one of  
the novel LEM-domain proteins, termed LEM3 or ANKRD41 (Lee and Wilson, 2004). We show 
that the LEM domain in LEM3 is functional in binding to BAF, which confirms that the protein 
is a bona fide LEM protein. In addition, we also demonstrate various intriguing new and unique 
features of LEM3 within the LEM proteins: (A) LEM3 mRNA expression is mostly restricted to 
hematopoietic tissues, while most of the characterized mammalian LEM proteins are widely 
expressed (Brachner et al., 2005; Ellis et al., 1998; Lin et al., 2000; Theodor et al., 1997). (B) 
LEM3 molecular domain organization is clearly distinct from that of other members; its LEM 
domain is localized in the middle of the polypeptide, and it contains ankyrin repeats at the N-
terminal domain and a GIY-YIG motif at its C-terminal end. (C) LEM3 encodes smaller 
isoforms that lack a functional LEM domain and cannot bind BAF. Thus, LEM3 is so far the 
only LEM gene encoding isoforms that can or cannot bind BAF, indicating a potential role of 
LEM3 in BAF regulation or vice versa. (D) The most intriguing feature of LEM3 within the 
LEM family is probably its unique cellular localization. Whereas all characterized members of 
the LEM protein family are localized in the nucleus and except for LAP2α and ζ isoforms are 
anchored in the inner nuclear membrane (Wagner and Krohne, 2007), LEM3 is localized both in 
the nucleoplasm and cytoplasm and this localization depends on cell condition and species. Our 
data strongly suggest that LEM3 shuttles between the nucleus and cytoplasm and that shuttling is 
intrinsic to the protein and independent of the cell type; hLEM3 is effectively exported from the 
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nucleus and localizes to actin fibers, while mLEM3 tends to accumulate in the nucleus. We 
speculate that a mouse sequence-specific Leucin to Tryptophan substitution in a putative NES in 
the human protein at position 115 might be responsible for the different behaviour (Kutay and 
Guttinger, 2005).  
 
What may be the function of LEM3?  
We found that hLEM3α, when forced to accumulate in the nucleus by transiently inhibiting 
nuclear export, caused  BAF displacement from diffused nucleoplasmic distribution into 
cytoplasmic aggregates. As hLEM3α did not colocalize with cytoplasmic BAF aggregates we 
speculate that interaction between both proteins might be restricted to the nucleus. Interaction 
between LEM3α and BAF might be only transient or could be regulated by post-translational 
modifications of hLEM3 or BAF in the nucleus (data not shown).  
In silico analyses revealed a high degree of conservation in domain organization of LEM3 
orthologues from H. sapiens, M. musculus, D. melanogaster, to C. elegans. The highest level of 
conservation was detected in the C-terminal region of the molecule, containing the GIY-YIG 
motif, indicating important functions of this domain. The GIY-YIG motif is related to the 
conserved COG3680a domain present in bacterial or phage proteins with endonuclease and/or 
recombinase activities (Dunin-Horkawicz et al., 2006; Van Roey et al., 2002). It is tempting to 
speculate, therefore, that LEM3 may also be involved in cellular processes involving nuclease 
activities. While bacterial GIY-YIG endonucleases also contain an additional DNA-binding, 
mostly a zinc-finger domain, LEM3, which misses a predictable zinc finger domain, could bind 
to DNA via the interaction of its LEM domain with BAF. Following this model, LEM3 splice 
isoforms lacking the LEM domain function are predicted to exert inefficient DNA binding and 
nuclease activity. Consistent with a function of LEM3 in nuclease-involving pathways is the 
observed association of LEM3 with RNA-processing factories (supplementary figure), which are 
known to be functionally linked to double-strand break DNA-repair complexes (Campalans et 
al., 2007; Herrmann et al., 2007). Intriguingly, BAF-emerin and BAF-LAP2α complexes (Jacque 
and Stevenson, 2006; Suzuki et al., 2004; Van Maele et al., 2006) were also found to be involved 
in the integration of viral DNA into the host DNA, which also involves double strand breaks. In 
view of the high expression levels of LEM3 in B-cells, it is tempting to speculate that LEM3 and 
BAF are predominantly involved in DNA repair/recombination pathways during B-cell 
development. Interestingly, transcript levels of LEM3 are decreased upon long-term stimulation 
of RAMOS B-cells with anti-human IgM antibodies (A. Brachner, unpublished data), consistent 
with a function of LEM3 during B-cell differentiation. Smaller LEM3 isoforms, hLEM3β and 
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hLEM3γ, which miss a functional BAF-binding LEM motif may further regulate this activity 
(data not shown).  
 
Another potential function of LEM3 may be mediated by the ankyrin repeats, located in the N-
terminus of LEM3. The ankyrin repeat (AR) is one of the most abundant protein motifs, found in 
more than 400 different human proteins (Mosavi et al., 2004; Sedgwick and Smerdon, 1999). 
The number of repeats within a stretch of ankyrin motifs can range from one to over 30, but two 
to six consecutive repeats seem to be most common (Mosavi et al., 2004). Generally, ARs are 
thought to be universal platforms for protein-protein interaction, and proteins containing ankyrin 
repeats are involved in a multitude of cellular processes including signaling, transcription, 
inflammation and development (Mosavi et al., 2004). Interaction partners of the AR in LEM3 are 
not known yet.  
 
LEM-3 was also identified in a recent RNAi-screen for genes involved in axon guidance in 
C.elegans (Schmitz et al., 2007). Based on the detection of LEM3 EST sequences in murine 
sympathetic ganglion (NCBI Unigene database) and a moderate expression observed in human 
brain shown here, a role of LEM3 in neuronal development can also be envisaged.  
 
 
Materials and Methods 
Cell culture and reagents 
HeLa cells and the primary embryonic rat cell clone oREC (Cerni et al., 1990) were routinely 
cultivated in DMEM supplemented with 10% fetal calf serum (Invitrogen, Carlsbad, USA), 
100 U/mL Penicillin/Streptomycin and 2 mM L-Glutamine at 37°C in a humidified atmosphere 
containing 8,5% CO2. Transient transfections were performed using Lipofectamine 2000 
according to the manufacturer’s instructions (Invitrogen, Carlsbad, USA). Pharmacological 
intervention of Crm-dependent nuclear export was done by treatment of cells with 10 ng/mL 
Leptomycin B (Sigma, Munich, Germany) in complete growth medium for 3 hours. 
 
PCR analysis 
Total RNA was purified from cell lines by standard techniques or purchased as total RNA 
collections of human and mouse tissues (Human and mouse total RNA Master Panel II, 
Clontech, Palo Alto, USA). Poly(A)+-mRNA was extracted from total RNA using the mRNA-
Isolation Kit and reverse transcribed using the first-strand cDNA Synthesis Kit (both from 
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Roche, Mannheim, Germany). Aliquots of the resulting products were used as templates for 
PCR-amplifications using the Go-Taq PCR Kit (Promega, Mannheim, Germany) and primers as 
listed in Supplementary Table 1. cDNA levels were normalized for actin expression levels. 
 
Primers used for determination of 
expression 
Sequence 5’ – 3’ 
human, mouse, rat Actin forward ATC TGG CAC CAC ACC TTC TAC 
human, mouse, rat Actin reverse CAG CCA GGT CCA GAC GCA GG 
human LEM3 all isoforms forward CCA GCC CGA GCC TTC TCA CTG AC 
human LEM3 all isoforms reverse CGC TCG CCT TCA GCC AGG AAG AC 
mouse LEM3 all isoforms forward ACT GGC GGA GGC ACT AAG GAC AGG 
mouse LEM3 all isoforms reverse CCG AGA GGG TGG CCA ATG GGC AAC 
human LEM3 splice isoforms forward TGC CTG TGG GAG CAC CAG ACA TC 
mouse LEM3 splice isoforms forward AAC CCG TAC TGC CTG GTG ATG G 
rat LEM3 splice isoforms forward ACC CTT ACT GCT TGG TGA TG 
rat LEM3 splice isoforms reverse TCA GCC TCG AGC CTG AAT GTC 
 
Primers used for cloning Sequence 5’ – 3’ 
human LEM3 forward CAC CGC TAG CAT GTG CTC GGA GGC CCG CCT GG
human LEM3 reverse GTA TCT AGA GCC CCG GGC CTG GAT GTC 
mouse LEM3 forward CAC CTG GGA CAT GGC CGA TAC TGC ATG CTT GG 
mouse LEM3 reverse GGA GCC TCG AGC CTG AAT GTC CTG A 
Table 1: Primers used for cloning and PCR analyses. 
 
Antibodies 
Mouse anti-V5 antibodies were purchased from Invitrogen (Carlsbad, USA); mouse anti-alpha-
tubulin, anti-vimentin, and anti SC-35, and rabbit sera against actin and V5 from Sigma 
(Munich, Germany). Anti-LAP2α antibody was described previously (Vlcek et al., 2002), 
antiserum to BAF was a generous gift of K. Furukawa (Niigata University, Niigata, Japan; 
(Furukawa, 1999), the H20 antiserum generated against the cap structure of U snRNAs was 
kindly provided by R. Lührmann (Max-Planck-Institute for Biophysical Chemistry, Göttingen, 
Germany (Bochnig et al., 1987); and the monoclonal antibody 4B10 recognizing hnRNP-A1 was 
generously provided by G. Dreyfuss (University of Pennsylvania School of Medicine, 
Philadelphia, USA; (Choi and Dreyfuss, 1984)). 
 
Plasmids and cloning strategy 
Human and mouse full length LEM3 and splice variants were amplified by PCR using bone 
marrow cDNA and Pfx-polymerase (Invitrogen, Carlsbad, USA). For primers, see Table 1. PCR 
products were cloned either directly into pENTR/D-TOPO by Topoisomerase based cloning 
(Invitrogen) or cut with SalI and XbaI and cloned into NheI and XbaI sites of the peGFP-C1 
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vector (Clontech, Palo Alto, USA). For eukaryotic expression of V5 tagged proteins, hLEM3 
was shuttled with the LR-recombination reaction (Invitrogen) into pTRACER-B, made 
Gateway®-compatible by insertion of the “conversion cassette” into the EcoRV site. Vectors 
expressing deletion mutants of hLEM3 were constructed by cloning PCR-generated hLEM3 
fragments into peGFP-C1 using the same cloning strategy. The expression plasmid pTRACER-
LEM2FL encoding full length human LEM2-V5 was described previously (Brachner et al., 
2005). 
 
Subcellular fractionation, gel electrophoresis and immunoblotting 
To prepare total lysates, cells were scraped off, washed in cold PBS and resuspended in cold 
high-salt RIPA buffer (25 mM Tris-HCl pH 7.4, 500 mM NaCl, 1% NP-40, 1% sodium 
deoxycholate, 0.1% SDS, “Complete” protease inhibitor mix (Roche, Mannheim, Germany)). 
For subcellular fractionation cells were incubated in hypotonic buffer H (10 mM HEPES pH 8.0, 
10 mM KCl, 100 µM EDTA, 100 µM EGTA, 1 mM DTT) for 15 minutes on ice, NP-40 was 
then added to 0,5% final concentration and cells were vortexed for 10 seconds and nuclei spun 
down in a table centrifuge at 13.000 g for 1 minute. The supernatants containing cytoplasmic 
proteins, and nuclei in the pellet nuclei were washed in buffer H , resuspended in high salt RIPA 
and analyzed by SDS-PAGE and immunoblotting . 
 
Co-Immunoprecipitation 
Cells were scraped off the plates, washed in ice cold PBS plus 1mM NaVO4 (Sigma, Munich, 
Germany) and lysed in CoIP lysis buffer (50 mM Tris-HCl pH 7.4, 4 mM MgCl2, 10 mM β-
Glycerophosphat, 150 mM NaCl, 0.1% SDS, “complete” protease inhibitor cocktail (Roche), 
1% Triton X-100, 1 mM NaVO4) on ice for 15 minutes. Insoluble material was removed by 
centrifugation at 300 g for 5 minutes. Supernatants were pre-cleared with BSA-adsorbed G-
protein-coupled sepharose beads (Sigma, Munich, Germany) and incubated either with beads 
alone or beads coupled to monoclonal anti-V5 antibodies (Invitrogen, Carlsbad, USA) for 2 
hours at 4°C. Immunoprecipitates were washed in lysis buffer, eluted in Laemmli sample buffer 
and analyzed by immunoblotting (Gerner et al., 2002). 
 
Immunofluorescence and live-cell microscopy 
Cells were grown on poly-L-lysine-coated glass coverslips, fixed in methanol at –20°C for 
1 minute, or alternatively fixed in 4% paraformaldehyde for 10 minutes and permeabilized in 
PBS / 0.5% Triton X-100 for 5 minutes. Cells were blocked in PBS / 0.5% gelatine for 15 
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minutes, incubated with primary antibodies for 45 minutes, washed and re-probed with the 
appropriate secondary antibodies conjugated to either TexasRed, Cy-3, Cy-5 (Jackson Immuno 
Research, West-Grove, USA) or Alexa-488 (Molecular Probes, Leiden, The Netherlands) for 45 
minutes. DNA was counter-stained with 100 ng/mL DAPI (Sigma, Munich, Germany) for 5 
minutes, and samples were mounted in Mowiol (Fluka, Buchs, Switzerland) and viewed with a 
confocal laser scanning microscope (LSM-Meta, Zeiss, Jena, Germany) using a Plan-
Apochromat 63x oil immersion objective (NA=1.40). Live-cell imaging was performed by 
seeding transfected cells into ibidi-treat® microscopy slides (Ibidi, Munich, Germany). Digital 
images were analyzed, adjusted for brightness and contrast, and mounted using the LSM-Image-
Browser (Zeiss, Jena, Germany) and Adobe Photoshop (Adobe Systems Inc, San Jose, USA). 
 
C. elegans strains, antibodies and RNAi mediated experiments 
C. elegans N2 and VC237 strains were obtained from the C. elegans Genome Center and 
cultured as described previously (Brenner, 1974). tm1582 was obtained from Shohei Mitani, 
(Tokyo Women's Medical University School of Medicine, Tokyo). YG1002 strain expressing 
GFP-BAF-1 is described in (Margalit et al; 2007). Both the emr-1 deletion strain, VC237, and 
the lem-2 deletion strain, tm1582, were outcrossed three times. The strain homozygous for lem-2 
deletion and heterozygous for emr-1 deletion was obtained using the VC237 and tm1582 strains.   
Clone I-4B14 (for lem-3 RNAi, MRC Gene Service) or the empty L4440 construct were used for 
RNAi feeding at 16°C as described (Fridkin et al., 2004). Worms were either examined live for 
viability and brood size or collected for RT-qPCR as described (Margalit et al., 2007). Worms 
were also fixed and stained for indirect immunofluorescence using the following antibodies: 
Rabbit anti-Ce-lamin sera 3932 or Rabbit anti-Ce-emerin sera 2570 were used at 1:100 dilution. 
Immunostained embryos and live worms expressing GFP constructs were imaged by using a 
Zeiss Axioplan II microscope equipped for fluorescence. The following primers were used for 
RT-qPCR: For lem-3, forward 5’-cctgcaattgctgctgtaaa-3’, reverse 5’-gttggcttggatggtgtttt-3’ or 
forward 5’-acatgaaatatcccacggag-3’, reverse 5’-ccttccagcttcaaagttga-3’. For cah-3, forward 5'-
cacttccattggggagagaa-3', and reverse 5'- acaacgcctttccctctttt -3'. 
 
Computer-assisted analysis 
Alignments of cDNA sequences and database searches were performed by NCBI-BLAST 
(http://www.ncbi.nlm.nih.gov/blast/), GraphAlign (http://darwin.nmsu.edu/cgi-
bin/graph_align.cgi) (Spalding and Lammers, 2004) and ClustalW 
(http://www.ebi.ac.uk/clustalw/) (Thompson et al., 1994). Genomic analysis was done using the 
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ENSEMBL-Genome Browser (http://www.ensembl.org/) (Sanger Institute). The sequences of 
hLEM3 orthologues were predicted using the GENSCAN software 
(http://genes.mit.edu/genscan.html) (Burge and Karlin, 1997). Protein motifs and pattern 
searches were performed using SMART (http://smart.embl-heidelberg.de/) (Letunic et al., 2004; 
Schultz et al., 1998), CDD (NCBI; http://www.ncbi.nlm.nih.gov/) and PSORT-II 
(http://psort.nibb.ac.jp/form2.html). Transmembrane domains were calculated using the 
membrane protein topology database (http://blanco.biomol.uci.edu/mptopo/) (Jayasinghe et al., 
2001), the TMHMM 2.0 prediction software (http://www.cbs.dtu.dk/services/TMHMM/) (Krogh 
et al., 2001), the SOSUI system (http://sosui.proteome.bio.tuat.ac.jp/) and the DAS-TMfilter 
algorithm (Cserzo et al., 2004). Phylogenetic tree predictions were visualized using the 
PhyloDraw software (Choi et al., 2000). 
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3.3.2 LEM3, a novel Player in DNA Recombination/Damage Response? 
Damage of genomic DNA, which occurs during replication, after exposure to reactive chemicals 
or high-energy irradiation, represents a serious threat to individual cells. For unicellular species, 
it is essential to repair most of the occurring genomic mutations to maintain the genetic 
information that defines its characteristics. Multicellular organisms not only need to maintain 
their genomic identity, but mutations also pose a serious threat for the whole organism, as 
genetic alterations may ultimately lead to deregulated cell proliferation and cancer (Wahl and 
Carr 2001). Therefore mechanisms to detect and repair damaged DNA developed very early in 
evolution and are found in all organisms existing today (Aravind et al. 1999). The cellular DNA 
repair machinery has to deal with two main types of DNA damages: (1) Single strand DNA 
lesions that include nucleotide mismatches, single strand DNA breaks, DNA adducts and 
thymidine dimers and (2) DNA double strand breaks (Essers et al. 2006; Li and Zou 2005). 
According to the type of DNA damage specific repair pathways are activated: Nucleotide- and 
base excision repair proteins remove single strand lesions whereas double strand breaks are 
mostly repaired by the homologous or non-homologous end joining machinery (Wood et al. 
2005). An early sensor of DNA double strand breaks in eukaryotes is a minor variant of Histone 
H2A, termed Histone H2A.X (H2A.X) (Rogakou et al. 1998). After DNA lesion H2A.X is 
instantly phosphorylated by the kinases ATM (Ataxia-Telangeiectasia Mutated gene) (Burma et 
al. 2001), ATR (Ataxia-Telangeiectasia and Rad3-related gene) (Ward and Chen 2001) or DNA-
PK (DNA-activated Protein Kinase) (Stiff et al. 2004) depending on the primary cause of insult. 
The phosphorylation of H2A.X (abbreviated as γH2A.X) leads to the formation of DNA-damage 
foci and consequently triggers several pathways leading to activation of DNA-repair, cell cycle 
arrest or apoptosis (Rogakou et al. 1998). 
Higher metazoan organisms not only have to cope with DNA lesions arising “accidentally”, but 
also insert under distinct circumstances double strand breaks in the genome on purpose. The best 
investigated and understood situation for such specifically inserted DNA damages are the 
somatic recombination events during the differentiation of B-and T-cells. In fact, the site-specific 
V(D)J recombination in B-and T-cells is crucial for a functional, adaptive immune system to 
defeat pathogens. On the other hand, recombination processes include a serious risk for the 
whole organism in case of uncontrolled genomic rearrangements which eventually can generate 
tumorigenic cells (Marculescu et al. 2002). Surprisingly, immunocompetent cells are not the 
only ones undergoing genomic recombination in higher metazoan species. Murine and zebrafish 
neurons also express proteins known to be involved in somatic recombination in lymphoid cells, 
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such as RAG1 (Recombination Activated Gene 1) (Chun et al. 1991; Feng et al. 2005; Jessen et 
al. 2001; Matsuoka et al. 1991).  
Not unexpectedly, many factors that are involved in DNA damage repair were also found to play 
a role in recombination, such as proteins of the non-homologous-end-joining repair pathway 
(Larijani et al. 2005). Accordingly, ATM, H2A.X and several other components of the DNA 
damage response pathway have been reported to be essential in lymphoid cell differentiation. 
γH2A.X was found in foci at the T-cell receptor α (TCRα) gene in immature T-cells undergoing 
TCRα recombination (Chen et al. 2000) and was found to be necessary for V(D)J- and class 
switch recombination in differentiating B-cells (Chen et al. 2000; Gellert 2002; Reina-San-
Martin et al. 2003). Furthermore γH2A.X was discovered during male meiosis where it was 
found to be required for condensation and meiotic pairing of X and Y chromosomes (Fernandez-
Capetillo et al. 2003; Hunter et al. 2001) and additionally it is upregulated upon initiation of 
DNA fragmentation during apoptosis (Rogakou et al. 2000).  
We have identified LEM3 as a novel, evolutionary conserved LEM protein expressed in a tissue 
and cell type restricted manner in mammals. The restricted expression pattern lead us to 
speculate about a potential role in B-cells (see also chapter 3.3.1) but minor amounts of LEM3 
mRNA were also detected in brain, testis and thymus. Furthermore, we found a highly conserved 
C-terminal region in LEM3 with a predicted GIY-YIG motif (Dunin-Horkawicz et al. 2006). As 
this motif has previously been detected in several proteins with nuclease activity, this may 
indicate a role of LEM3 in DNA recombination or damage repair. Intriguingly, upon 
overexpression of LEM3 in cells we found a strong activation of several components known to 
be involved in DNA damage response, namely ATM, γH2A.X, Chk2 and p53, suggesting that 
LEM3 either causes DNA damage itself by its predicted nuclease activity or that it may act as a 
sensor of DNA damage or an activator of the repair response. 
 
Results 
Ectopic LEM3 expression causes phosphorylation of ATM, H2A.X, Chk2 and p53 
In order to investigate a proposed involvement of LEM3 in DNA-damage response we examined 
induction of γHistone 2A.X in UV-treated oREC and HeLa cells. At different time points (5, 10, 
30, 60 minutes) post irradiation with 50J/m2 we did not detect a significant difference in the  
number of γHistone 2A.X positive cells or signal intensity (data not shown) between 
untransfected control and LEM3-overexpressing cells. However, cells ectopically expressing 
human or murine LEM3 showed clearly phosphorylated H2A.X without UV treatment (Fig. 38). 
Interestingly, H2A.X phosphorylation was also significantly affected by the localization of 
ectopic human LEM3-V5. Expression of mLEM3-V5 in oREC cells, which is predominantly 
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nuclear, caused a prominent upregulation of γH2A.X as revealed by immunofluorescence 
(Fig. 38, second row). Human LEM3, in contrast, which is mostly cytoplasmic, only yielded a 
mild increase in γH2A.X staining in immunofluorescence. However, treatment of hLEM3-V5 
expressing cells with the nuclear export inhibitor Leptomycin B, which caused hLEM3 to 
accumulate in the nucleus (see also chapter 3.3.1), also initiated robust upregulation of the 
γH2A.X stain, while Leptomycin B had no effect on γH2A.X in hLEM3-lacking untransfected 
cells. Thus, accumulation of LEM3 in the nucleus causes a dramatic increase in γH2A.X. This 
effect was specific for LEM3, since overexpression of the inner nuclear membrane protein 
hLEM2 did not cause upregulation of γH2A.X. 
 
Figure 38: oREC expressing human or murine LEM3-V5 were fixed and stained for V5 (green), 
γHistone 2A.X (red) and DNA (blue). Human LEM2-V5 served as a negative control for side 
effects of the transfection procedure. “+Leptomycin” indicates additional treatment with 
Leptomycin (10 ng/mL) for three hours prior to fixation. Graph: Untransfected and transfected 
cells on the same petridish were counted for positive γH2A.X staining (n>100 each). 
 
Next, we determined the phosphorylation status of several other components of the DNA 
damage response pathway in LEM3 expressing cells. We found a striking correlation between 
the ectopic expression of LEM3 in the nucleus and the phosphorylation of ATM, Chk2 and p53 
in MCF7 cells, indicating that the DNA repair pathway is activated in LEM3 expressing cells.  
A LEM3 deletion construct lacking the N-terminal Ankyrin repeats as well as the whole 
C-terminus (LEM3ΔAC) did not cause this effect and served together with untransfected cells as 
a negative control. Untransfected cells upon UV irradiation (1h post irradiation with 50J/m2) 
served as positive controls (Fig. 39A-D). As MCF7 cells are deficient for Caspase 3 (Kagawa et 
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al. 2001) γH2A.X is not observed upon induction of apoptosis (Rogakou et al. 2000). Therefore, 
we conclude that the observed activation of DNA damage repair proteins upon LEM3 expression 
is not triggered by an induction of apoptosis. 
 
 
 
 
 
Figure 39A: For negative control, parallel cultures of untreated MCF7 cells were fixed and 
stained for phosphorylated proteins involved in DNA damage response (red). DNA was 
visualized by DAPI staining (blue). Arrows indicate localization of phosphorylated Chk2 at 
centrosomes as described previously (Tsvetkov et al. 2003). 
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Figure 39B: UV-treated MCF7 cells were fixed and stained for phosphorylated proteins involved 
in DNA damage response (red) one hour post irradiation with 50J/m2. DNA staining (blue).  
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Figure 39C: MCF7 cells were transfected with a GFP-hLEM3α construct. 24h post transfection 
cells were treated with Leptomycin B for 3h. After Leptomycin treatment, they were fixed and 
stained for anti-phospho-ATM, anti-γH2A.X, anti-phospho-p53 and anti-phospho-Chk2 (red) 
DNA was stained with DAPI (blue). Marked cell in forth row (“phospho-Chk2”) is shown at 
higher magnification in the panel below. 
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Figure 39D: MCF7 cells were transfected with a GFP-hLEM3ΔANK,CT deletion construct. 24h 
post transfection cells were treated with Leptomycin for 3h and afterwards fixed and stained for 
anti-phospho-ATM, anti-γH2A.X, anti-phospho-p53 and anti-phospho-Chk2 (red). DNA was 
stained with DAPI (blue). 
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LEM3 might undergo post-translation modification within the nucleus 
Western blot analysis of cytoplasmic and nuclear fractions of cells transiently expressing mouse 
LEM3-V5 confirmed our previous observations in immunofluorescence microscopy showing 
that mLEM3 is found in the nucleus and cytoplasmic fraction and that it accumulates further in 
the nuclear fraction upon Leptomycin treatment. (Fig. 40, left blot, mLEM3). Intriguingly, the 
molecular weight of cytoplasmic versus nuclear mLEM3 differed significantly, revealing a 
higher molecular weight on SDS gels for nuclear LEM3 as compared to the cytoplasmic pool. 
This may point to a specific modification, probably a phosphorylation, of LEM3 specifically in 
the nucleus. Also immunoprecipitated human and murine LEM3-V5 ran faster on SDS gels than 
LEM3 in lysate inputs (Fig. 40, right blot), which may be caused by incomplete inhibition of 
phosphatases, and thus dephosphorylation of LEM3 during the precipitation procedure. 
 
Figure 40: Cells expressing mouse LEM3-V5 were applied to a crude subcellular fractionation 
procedure and cytoplasmic and nuclear enriched fractions were subjected to SDS-PAGE and 
immunoblotting (left blot) or V5-immunoprecipitation (right blot). Blots were probed with anti-
V5 antibodies. Cytoplasmic and nuclear fractions (C, N), immunoprecipitation input (I), 
supernatant (S) and precipitated protein (P). “IgG” indicates cross-reactive IgG light chain. 
 
Summary & Conclusions 
Genomic recombination and DNA damage response are two intimately linked processes. 
Multicellular organisms require an adaptive immune system in order to fight efficiently against 
vital threats posed by pathogens, harmful chemical compounds or malignant cells, which 
requires genetic rearrangements to create flexibility. The insertion of DNA breaks as needed for 
genetic rearrangements represents a high risk for the organism, as genomic aberrations can 
generate transformed cells, eventually leading to cancer. Indeed, a well-characterized reciprocal 
translocation between the BCR gene locus and the Abl-kinase, thereby forming the so-called 
“Philadelphia” chromosome, leads to a detrimental fusion product termed BCR/Abl. The 
dominant BCR/Abl fusion product is the causative factor for almost all cases of chronic 
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myelogenous leukemia as well as for a high percentage of acute lymphoblastic- and other forms 
of leukemia (Butturini et al. 1996; Salesse and Verfaillie 2002). Other examples for frequently 
observed aberrant genomic rearrangements in leukemia which cause a misexpression of proto-
oncogenes involve bcl-2, an inhibitor of apoptosis, and the transcription factor c-myc 
(Korsmeyer 1992).  
Intriguing and so-far unclear are several studies reporting expression of RAG1 in neuronal 
samples, which forms together with RAG2 the recombinase responsible for V(D)J and T-cell 
receptor recombination in lymphoid cells (Fugmann 2001). Based on this, it was speculated that 
both immunogenic and neurogenic cell differentiation pathways use genetic rearrangements in 
order to create the enormous heterogeneity inherent to both systems (Chun and Schatz 1999). 
Interesting in this context is, that LEM3 was also detected at low levels in brain tissue (see also 
chapter 3.3.1) and was found to be highly expressed in murine sympathetic ganglia (NCBI 
Unigene database, http://www.ncbi.nlm.nih.gov/sites/entrez?db=unigene). Two recent screens 
performed in C.elegans mentioned ce-lem-3 to be involved in axon guidance and to be expressed 
in motor neurons, respectively (Fox et al. 2005; Schmitz et al. 2007). 
Furthermore, recombination events take place at high frequency in meiosis during maturation of 
germ cells (about 100-1000 fold more often than during mitosis) (van Heemst and Heyting 
2000). Intriguingly, this coincides also with elevated LEM3 expression in testis tissue (see also 
chapter 3.3.1). 
Therefore, we speculate about a role of LEM3 in DNA recombination and/or the subsequent 
repair procedure. Our working hypothesis is further corroborated by the finding that LEM3 
contains a predicted GIY-YIG motif (Dunin-Horkawicz et al. 2006), which was previously 
identified to be linked to nuclease activity in bacterial and phage proteins. 
Ectopic expression of human or murine LEM3 resulted in a strong activation of the ATM-
dependent signaling pathway. Consistent with our previous notion that human LEM3 represents 
a nucleo-cytoplasmic shuttling protein (see also chapter 3.3.1) this effect was less pronounced in 
untreated cells when hLEM3 resides primarily in the cytoplasm. We suggest that the low levels 
of γH2A.X detected in untreated hLEM3 expressing cells result from minimal amounts of 
hLEM3 in the nucleus not detectable at steady state in fixed specimen. Whether hLEM3 triggers 
H2A.X phosphorylation by itself, for instance by causing DNA damage, which would result in 
turn in phosphorylation of H2A.X and activation of the DNA damage response cascade, or by an 
indirect way is currently under investigation. According to data obtained in experiments using 
MCF7 cells, which were shown to lack induction of γH2A.X upon chemically induced apoptosis 
due to a lack of Caspase-3 activity (Kurokawa et al. 1999; Rogakou et al. 2000), we conclude 
that the observed H2A.X phosphorylation is not a consequence of LEM3-provoked apoptosis. 
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Interestingly, we also noticed a partial co-localization of LEM3 and phosphorylated Chk2 at 
nuclear speckles, which may indicate a direct or indirect association of these proteins, indicating 
that LEM3 might also be involved in the DNA repair pathway itself. Noteworthy Chk2 is also 
found at the centrosomes in non-damaged cells (Tsvetkov et al. 2003) and we also noticed partial 
localization of human and murine LEM3 at centrosomes (data not shown). This finding might 
become relevant in view of a recently published in vitro screen for novel potential 
chemosensitizers upon treatment of cancer cells with the therapeutic drug Taxol. This screen 
found LEM3 as one candidate gene for providing protection against Taxol treatment (Whitehurst 
et al. 2007). 
If LEM3 indeed functions in recombination, a stringent regulation of (1) expression, (2) 
localization and (3) activity would be predicted. All three aspects are found for LEM3: (1) 
expression is limited to certain tissues and alternative splicing may fine-tune full length LEM3 
functions; (2) ectopic human LEM3 is strictly excluded from the nucleus by an active Crm-
dependent export mechanism, contrary to the localization of the murine ortholog which may be 
differently regulated; (3) potential posttranslational modification observed for nuclear human 
and murine LEM3 let us speculate about another level of regulating LEM3 functions. Taken 
together our findings so far are consistent with a role of LEM3 in recombination being a protein 
with essential but also potentially harmful functions. 
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Materials & Methods 
Cell culture, transfection procedures and UV irradiation 
HeLa and MCF7 cell lines and the embryonic primary rat cells oREC (Cerni et al. 1990) were 
routinely cultivated in DMEM supplemented with 10% fetal calf serum, 2 mM L-Glutamine and 
100 U/mL Penicillin/Streptomycin at 37°C in a humidified atmosphere containing 5% CO2. 
Transient cell transfections were done with Lipofectamine 2000 (Invitrogen) according to the 
manufacturers recommendations. Induction of apoptosis was done by administration of 1 µM 
Staurosporine (Sigma) in growth medium for the indicated period. Irradiation of cells with UV 
was performed using a UV-Stratalinker (Stratagene) set to an energy dose of 50 J/m2. 
 
Cloning strategy and plasmids 
Plasmids pTB-hLEM3 and pTB-mLEM3 are described in chapter 3.3.1, “Material and Methods” 
section. The vector pTB-hLEM2 containing full length human LEM2 cDNA was described 
previously (Brachner et al. 2005). 
 
Immunofluorescence microscopy & antibodies 
Immunofluorescence procedures were performed essentially as described previously (Brachner 
et al. 2005). Briefly, cells were grown on cover slips, washed with PBS once and fixed with ice-
cold methanol at -20°C for 2 minutes. After blocking with 0,5% Gelatine/PBS, cells were 
incubated with primary antibodies, washed 3 times with PBS and probed with fluorescently 
labeled secondary antibodies. Following three washes with PBS, DNA was stained with DAPI 
(100 ng/mL) (Sigma) and embedded in MOWIOL (Fluka). Antibodies used in this study were a 
monoclonal antibody against V5 (Invitrogen) and a mouse anti-γHistone 2A.X purchased from 
Upstate. All images were taken on a Zeiss LSM-Meta confocal laser scanning microscope 
(Zeiss), adjusted for brightness and contrast using the LSM Image browser software (Zeiss) and 
mounted with Photoshop and Illustrator (both Adobe). 
 
Cellular fractionation, immunoprecipitation and Western blotting 
Cellular fractionation and Western blotting were performed essentially as described previously 
(Brachner et al. 2005). Immunoprecipitation procedures have been described in chapter 3.3.1, 
“Materials and Methods” section. 
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3.3.3 LEM3, Conclusions & Outlook 
LEM3 represents a novel type of LEM domain protein, regarding its localization, domain 
topology and potential functions. LEM proteins have been found so far only within the nucleus, 
most of them (except for LAP2α) residing within the INM. Emerin, LEM2, MAN1, and LAP2 
were shown to interact directly with nuclear Lamins (Brachner et al. 2005; Clements et al. 2000; 
Harris et al. 1995; Mansharamani and Wilson 2005). It is not known whether LEM3 binds to 
Lamins too. Tissue restricted expression of LEM3 hints to a role in lymphoid cells. From an 
evolutionary perspective, LEM3 may have evolved from an ancient protein involved in general 
DNA damage response, which may have taken over specialized functions associated with 
recombination- or somatic hypermutation in the differentiation of lymphoid cells. In support of 
this putative conserved function, a highly conserved motif in the C-terminal part of LEM3 was 
identified in a computational screen, termed GIY-YIG domain (Dunin-Horkawicz et al. 2006). 
The GIY-YIG motif was previously found to be linked to nuclease functions in bacterial and 
viral proteins (Dunin-Horkawicz et al. 2006; Van Roey et al. 2002).  
Intriguingly, we observed a strong coincidence between an experimentally induced presence of 
LEM3 in the nucleus and activation (phosphorylation) of proteins involved in DNA damage 
response and repair, such as Histone 2A.X, ATM, Chk2 and p53 (chapter 3.3.2). Ectopically 
expressed human and murine LEM3 co-localized with cytoplasmic Actin stress fibers, γ-Tubulin 
and nuclear splicing speckles, all of these proteins have been associated with DNA damage 
response or repair previously (Campalans et al. 2007; Herrmann et al. 2007; Lesca et al. 2005; 
Okorokov et al. 2002). 
A comprehensive expression analysis of LEM3 in different phases of B-cell development will be 
important in future studies to test whether LEM3 expression coincides with a certain 
differentiation stage. Further on, a knockdown of LEM3 in differentiating pre-B-cells or a 
knockout mouse model might yield fascinating new insights into the functions of LEM3. 
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5. Appendix 
Abbreviations 
 
AP1  Activator Protein 1 
ATM  Ataxia-Telangeiectasia Mutated gene 
ATR  Ataxia-Telangeiectasia and Rad3-related gene 
BAF  Barrier-to-Autointegration Factor 
Chk2  Checkpoint protein 2 
CT  C-Terminus 
DCM  Dilated CardioMyopathy 
DNA-PK DNA-activated Protein Kinase 
DMEM Dulbecco’s Modified Eagles Medium 
EDMD Emery-Dreifuss Muscular Dystrophy 
ER  Endoplasmic Reticulum 
esp  yeast Separin 
FCS  Fetal Calves Serum 
FPLD  Familial Partial Lipo-Dystrophy 
GFP  Green Fluorescent Protein 
H2A.X  Histone 2A.X 
γH2A.X phosphorylated Histone 2A.X 
heh  yeast helix-extension-helix containing gene 
HGPS  Hutchison-Gilford Premature aging Syndrome 
INM  Inner Nuclear Membrane 
KASH  Klarsicht, ANC1, SYNE1 Homology 
LAP2  Lamina-Associated Polypeptide 2 
LEM  LAP2, Emerin, MAN1 
lmna  murine Lamin A/C gene 
MAN1  Man AntigeN 1 
NE  Nuclear Envelope 
NPC  Nuclear Pore Complex 
NT  N-Terminus 
NUP  NUcleoPorin 
ONM  Outer Nuclear Membrane 
PAGE  PolyAcrylamide Gel Electrophoresis 
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PCR  Polymerase Chain Reaction 
RAG  Recombination Activated Gene  
RFP  Red Fluorescent Protein 
RNAi  RNA interference 
RT-PCR Reverse Transcription-PCR 
SAP  SAF A/B, Acinus, PIAS 
scc  yeast Securin 
src1  yeast Spliced mRNA and cell Cycle-regulated gene 
SUN  Sad1-UNC84 homology 
V(D)J  Variable (Diversity) Joining 
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